Acute Tubular Necrosis
Acute tubular necrosis is the death of renal tubular epithelial cells, most commonly caused by ischemia or nephrotoxins, leading to intrinsic acute kidney injury.
Acute Tubular Necrosis (ATN)
Acute Tubular Necrosis (ATN) — sometimes now called Acute Tubular Injury (ATI) — is a form of intrinsic acute kidney injury (AKI) caused by ischaemic or nephrotoxic insult to the renal tubular epithelial cells, resulting in their death (necrosis), sloughing into the tubular lumen, and a consequent abrupt decline in kidney function [1][2].
Let's break down the name:
- Acute = sudden onset (hours to days)
- Tubular = affecting the renal tubules (the workhorses of reabsorption and secretion)
- Necrosis = cell death (Greek: nekrosis = death of tissue)
The modern shift towards the term "Acute Tubular Injury" reflects the understanding that the histological spectrum ranges from sublethal cell injury (swelling, loss of brush border) all the way to frank necrosis — many cells are injured but not yet dead, and the process is potentially reversible [3].
2. Epidemiology
- ATN is the MOST common cause of AKI in hospitalised patients, accounting for approximately 45–50% of intrinsic renal AKI cases [2][4].
- In the community, prerenal azotaemia is the most common cause of AKI overall (> 50%), but if left untreated, it progresses to ischaemic ATN — so ATN is also the most important cause of community-acquired acute renal failure [5].
- In ICU settings, ATN is overwhelmingly the dominant cause of AKI, driven by sepsis, shock, and nephrotoxin exposure.
- Hospital-acquired AKI occurs in ~5–7% of all hospital admissions; ATN accounts for the bulk of intrinsic renal causes.
- Mortality in ATN requiring dialysis in the ICU setting remains high (~50%), though the condition itself is potentially reversible if the underlying insult is removed.
- Elderly patients and those with pre-existing CKD, diabetes, heart failure are at highest risk.
- In Hong Kong, contrast-induced nephropathy (a form of ATN) is particularly relevant given the high volume of percutaneous coronary intervention (PCI) and CT contrast studies in an ageing population.
- Aminoglycoside-induced ATN remains important in local practice given ongoing use of gentamicin/amikacin for Gram-negative infections [6].
- Drug-related ATN from traditional Chinese medicines (e.g. aristolochic acid-containing herbs) causing tubular and interstitial injury has been specifically documented in Hong Kong and Southern China.
3. Relevant Anatomy and Function of the Renal Tubules
Understanding why the tubules are so vulnerable to injury requires understanding their anatomy and metabolic demands.
- Each kidney contains ~1 million nephrons.
- Each nephron consists of:
- Glomerulus (filtration)
- Proximal convoluted tubule (PCT) — bulk reabsorption
- Loop of Henle — countercurrent mechanism
- Distal convoluted tubule (DCT) — fine-tuning
- Collecting duct — final concentration/dilution under ADH control
The tubulointerstitium constitutes ~95% of the kidney volume [7]. So any pathology affecting this compartment has massive functional consequences.
The PCT is the principal site of injury in ATN. Why?
- Highest metabolic demand: The PCT reabsorbs ~65% of filtered sodium, water, glucose, amino acids, and bicarbonate. This requires enormous amounts of ATP (via Na⁺/K⁺-ATPase on the basolateral membrane). The PCT cells are packed with mitochondria.
- Rich brush border: The apical brush border massively increases surface area for reabsorption. It is the first structure to be damaged and lost in ATN — "rarification then disappearance of the brush border" [6].
- Drug concentration: Many nephrotoxic drugs (aminoglycosides, cisplatin, tenofovir) are actively taken up and concentrated in PCT cells via endocytosis at the brush border.
- Borderline oxygen supply: The renal medulla and the S3 segment of the PCT (the straight part, in the outer medulla) operate at a PaO₂ of only 10–20 mmHg — barely above the threshold for cell survival. Any drop in perfusion pushes these cells into ischaemia first.
The TAL actively pumps NaCl (via the Na⁺/K⁺/2Cl⁻ cotransporter, NKCC2) to generate the medullary concentration gradient. It has:
- High metabolic activity
- Location in the poorly oxygenated outer medulla
→ This makes it the second most vulnerable segment in ischaemic ATN.
- The outer medulla is supplied by the vasa recta (straight vessels branching from efferent arterioles of juxtamedullary glomeruli).
- These vessels run in a hairpin loop parallel to the Loop of Henle — efficient for countercurrent exchange but inherently at risk of ischaemia during hypoperfusion.
- Think of it as a "watershed zone" analogous to the brain — the region between two vascular territories most susceptible to ischaemia.
Why the Outer Medulla?
The S3 segment of the PCT and the thick ascending limb of the Loop of Henle both sit in the outer medulla — a zone with the highest metabolic demand but the most precarious oxygen supply. This is exactly where ischaemic ATN hits hardest.
4. Aetiology
ATN is broadly classified into two major aetiological categories: ischaemic and nephrotoxic. A third category — sepsis-associated — is increasingly recognized as having a distinct pathophysiology.
Core concept: Ischaemic ATN is the progression of prerenal failure [1][2][4]. If prerenal azotaemia (reversible hypoperfusion) is not corrected, sustained ischaemia causes tubular cell injury and death.
| Mechanism | Examples |
|---|---|
| Hypovolaemia | Haemorrhage, severe dehydration (vomiting/diarrhoea), burns, third-space losses |
| Cardiogenic shock | Acute MI, severe heart failure, cardiac tamponade |
| Distributive shock | Septic shock (most common cause of ATN in ICU), anaphylaxis |
| Effective hypovolaemia | Heart failure (↓ CO), liver cirrhosis (splanchnic vasodilation, ↓ effective circulating volume), nephrotic syndrome |
| Renal hypoperfusion | Renal artery stenosis, hepatorenal syndrome |
| Drugs affecting GFR | NSAIDs (↓ afferent arteriole dilatation), ACEI/ARB (↓ efferent arteriole constriction), calcineurin inhibitors (ciclosporin, tacrolimus — afferent arteriolar constriction) |
| Thrombotic microangiopathy | TTP, HUS, DIC |
| Vasculitis | Polyarteritis nodosa, ANCA-associated vasculitis |
| Major surgery / trauma | Prolonged intraoperative hypotension, post-cardiac surgery |
Important Nuance
Heart failure rarely causes ischaemic ATN despite being a cause of prerenal AKI [1]. This is because the kidney has autoregulatory mechanisms that can maintain GFR even at reduced perfusion pressures — HF usually gives prerenal azotaemia, not frank ATN, unless there is severe cardiogenic shock.
4.2 Nephrotoxic ATN
Nephrotoxins cause direct tubular cell injury through various mechanisms:
| Nephrotoxin | Mechanism / Notes |
|---|---|
| Aminoglycosides (gentamicin, amikacin) | Concentrated within the kidney at the phospholipid brush border of the proximal tubular epithelium → endocytosis → inhibits phospholipase → accumulation of lipids, modification of enzyme activities (e.g. Na⁺/K⁺-ATPase) → reduced lysosomal membrane permeability and mitochondrial respiration → tubular necrosis [6]. Also causes ototoxicity/vestibular toxicity. Classically causes non-oliguric ARF initially, preceded by polyuria and tubular dysfunction [6][8]. |
| Cisplatin | Direct PCT toxicity → tubular diseases resulting in hypokalaemia and hypomagnesaemia [9]. Another example of non-oliguric AKI [8]. |
| Amphotericin B | Inserts into cell membranes → increases membrane permeability → ion leak → tubular necrosis. Also causes renal vasoconstriction. |
| Tenofovir disoproxil fumarate (TDF) | Proximal tubular toxicity → Fanconi syndrome (glucosuria, aminoaciduria, phosphaturia). Tenofovir alafenamide (TAF) is safer for the kidneys [8]. |
| Radiocontrast agents | See "Contrast Nephropathy" below. |
| NSAIDs | Multiple mechanisms: inhibit prostanoid production → impaired renal blood flow regulation (prostaglandins prevent excessive vasoconstriction of afferent and efferent arterioles) [10]. Can also cause AIN, glomerulonephritis, and papillary necrosis. |
| Paracetamol (overdose) | Direct tubular toxicity, especially in overdose via toxic metabolite NAPQI. |
| Foscarnet | Direct tubular toxicity. |
| Heavy metals (lead, mercury, cadmium) | Direct tubular cell toxicity. |
| Statins | Rhabdomyolysis → myoglobin-induced ATN (indirect) [2]. |
| Bisphosphonates (pamidronate, zoledronic acid) | Direct tubular toxicity. |
| Toxin | Source | Mechanism |
|---|---|---|
| Myoglobin | Rhabdomyolysis (crush injury, statins, immobilization, seizures, heatstroke) | Myoglobin precipitates in tubules → direct oxidative injury → tubular obstruction. Dipstick +ve for blood but microscopy –ve for RBCs (myoglobin cross-reacts with haem on dipstick) [11]. |
| Haemoglobin | Haemolytic anaemia (intravascular haemolysis — TTP, HUS, transfusion reactions, G6PD crisis) | Free haemoglobin filtered → tubular toxicity + obstruction. |
| Monoclonal immunoglobulin light chains | Multiple myeloma | Light chains (Bence Jones proteins) precipitate in tubules → cast nephropathy. |
| Uric acid | Tumour lysis syndrome | Uric acid crystals precipitate in tubules → obstruction. |
| Bilirubin | Severe obstructive jaundice | Direct tubular toxicity at very high levels. |
| Calcium | Severe hypercalcaemia | Tubular injury via vasoconstriction and intratubular calcium deposition. |
This deserves special mention as it is very commonly tested and clinically important:
Cause: unclear, ?due to renal vasoconstriction [1]. Other proposed mechanisms include direct tubular toxicity and generation of reactive oxygen species.
- S/S: ↑Cr 24–48 hours after exposure to iodinated contrast, usually mild and starts to decline 3–7 days (faster recovery than other ATN) [1].
- Dx: usually clinical + urinalysis; FENa < 1% (unlike other ATN where FENa > 2%) [1].
- Mx: usually spontaneously resolves within 1 week [1].
- Prevention: avoid contrast CT if eGFR < 30; if absolute indication, use N-acetylcysteine + IV volume expansion before administration [1].
Contrast Nephropathy - Exam Point
Contrast nephropathy is unique among ATN causes because the FENa is typically < 1% (similar to prerenal), unlike other forms of ATN where FENa is > 2%. This is thought to be because the predominant mechanism is renal vasoconstriction (functionally similar to prerenal) rather than pure tubular necrosis. The sCr rise is typically mild and peaks at 3–5 days.
- Sepsis is the most common cause of ATN in the ICU setting.
- Mechanism is multifactorial: haemodynamic instability (distributive shock), microvascular dysfunction, direct tubular injury by inflammatory mediators (TNF-α, IL-1, IL-6), mitochondrial dysfunction.
- Kidney biopsy in sepsis-associated AKI often shows less necrosis than expected — suggesting that tubular cell dysfunction (apoptosis, cell cycle arrest, mitochondrial injury) rather than frank necrosis may predominate.
5. Pathophysiology
Understanding the pathophysiology of ATN explains every clinical feature and investigation finding. Let's walk through it step by step.
- Ischaemic or toxic insult → ATP depletion in tubular cells (especially PCT and TAL).
- Loss of cell polarity: Na⁺/K⁺-ATPase redistributes from basolateral to apical membrane → impaired directional sodium reabsorption.
- Loss of brush border: Actin cytoskeleton disruption → microvilli detach and shed into the lumen. Histology: "rarification then disappearance of the brush border" [6].
- Cell swelling: Failed Na⁺ extrusion → intracellular Na⁺ and water accumulation → cellular oedema.
- Intracellular calcium rise: Failed Ca²⁺ extrusion + release from mitochondria/ER → activates proteases, phospholipases, endonucleases → cell injury and death.
- Mitochondrial injury: Mitochondrial swelling [6] → further ATP depletion → positive feedback loop of injury.
- Lysosomal disruption: Enlarged lysosomes with myeloid bodies [6] (especially in aminoglycoside toxicity, where the drug accumulates in lysosomes).
- Cell death: Via necrosis (predominant in severe ischaemia) and apoptosis (predominant in milder injury and nephrotoxin exposure).
- Tubular cell sloughing: Dead and detached cells fall into the tubular lumen → form casts with Tamm-Horsfall protein.
- Muddy brown granular casts and epithelial cell casts — these are formed from the sloughed tubular cells and debris, and are pathognomonic for ATN [1][2].
- Tubular obstruction: Casts and cellular debris physically block the tubular lumen → ↑ intratubular pressure → opposes glomerular filtration → ↓ GFR.
- Backleak of filtrate: Denuded tubular basement membrane (where cells have sloughed off) allows filtrate to leak back into the interstitium → the kidney filters but cannot "keep" the filtrate in the tubule → ↓ effective GFR.
- Tubuloglomerular feedback (TGF) activation: Because the injured PCT cannot reabsorb sodium properly, excessive NaCl reaches the macula densa → TGF mechanism signals the afferent arteriole to vasoconstrict → ↓ GFR. This is actually a protective mechanism (to prevent further solute loss) but worsens overall kidney function.
- Inflammatory response: Injured tubular cells release DAMPs (damage-associated molecular patterns), chemokines, and cytokines → recruit neutrophils and macrophages to the interstitium → further tissue damage and oedema.
- Microvascular dysfunction: Endothelial injury in peritubular capillaries → loss of autoregulation, congestion, and further medullary hypoxia → vicious cycle.
- Surviving tubular cells undergo dedifferentiation → proliferation → redifferentiation to regenerate the tubular epithelium.
- Gradual normalization of GFR [2]
- Markedly increased urine output — up to 3 L/day [2] — because:
- Regenerating tubules cannot yet fully concentrate urine (immature tight junctions, insufficient Na⁺/K⁺-ATPase expression)
- Accumulated solutes (urea, Na⁺) act as osmotic diuretics
- "Urine output gradually returns to normal" [2]
- Risk during recovery: Dehydration and electrolyte disturbances (hypokalaemia, hyponatraemia) from the diuresis — must monitor closely!
Clinical Pearl - Polyuric Phase
The diuretic (polyuric) recovery phase is a dangerous time! Patients can become volume-depleted and develop hypokalaemia if not monitored. Replace fluids and electrolytes as needed, guided by daily weights and serum electrolytes.
Aminoglycosides and cisplatin classically cause non-oliguric AKI [8]. Why?
- These drugs primarily damage the PCT — the segment responsible for concentrating urine (reabsorbing water and solutes).
- If the PCT is damaged but the glomerulus is still filtering, the kidney produces large volumes of dilute, unconcentrated urine.
- So the creatinine rises (GFR is impaired) but the urine output is paradoxically normal or even increased.
- "Initially, non-oliguric acute renal failure → since the aminoglycosides affect renal tubular cells, impairing their ability to concentrate urine → patients may have an increase in serum creatinine, the patients may have diuresis (disjoint)" [8].
"So very different to classical acute kidney injury → since you would expect increase in serum creatinine, reduction in urine output" [8].
6. Classification
| Type | Mechanism | Key Examples |
|---|---|---|
| Ischaemic ATN | Progression of prerenal failure; sustained hypoperfusion | Shock (all types), major surgery, severe dehydration |
| Nephrotoxic ATN | Direct tubular cell injury by exogenous or endogenous toxins | Aminoglycosides, cisplatin, contrast, myoglobin, haemoglobin |
| Sepsis-associated ATN | Multifactorial: haemodynamic + inflammatory + microvascular | Sepsis/septic shock |
| Pattern | Definition | Typical Causes |
|---|---|---|
| Oliguric ATN | Urine output < 500 mL/day (or < 0.5 mL/kg/h) | Ischaemic ATN (most common pattern) |
| Non-oliguric ATN | Urine output normal or even increased despite rising creatinine | Aminoglycosides, cisplatin [8] |
Non-oliguric ATN generally has a better prognosis because the kidney is still producing urine (less fluid overload, less hyperkalaemia).
As described in pathophysiology:
- Initiation phase (hours)
- Extension phase (1–2 days)
- Maintenance/Oliguric phase (1–2 weeks)
- Recovery/Diuretic phase (days to weeks)
- Sublethal injury: Cell swelling, loss of brush border, vacuolization — no frank necrosis. Potentially fully reversible.
- Frank necrosis: Coagulative necrosis of tubular cells with sloughing. Still potentially reversible if basement membrane is intact.
- Basement membrane disruption: Most severe — loss of the scaffold for regeneration → risk of scarring and progression to CKD.
7. Clinical Features
| Symptom | Pathophysiological Basis |
|---|---|
| Reduced urine output (oliguria/anuria) | ↓ GFR from tubular obstruction, backleak, TGF-mediated vasoconstriction, and microvascular dysfunction. Note: non-oliguric ATN may have normal or increased urine output [8]. |
| Nausea and vomiting | Uraemia — accumulation of urea and other nitrogenous waste products that are normally excreted by the kidney. Urea is broken down to ammonia in the gut → irritates the gastric mucosa and stimulates the chemoreceptor trigger zone. |
| Fatigue and malaise | Uraemia, metabolic acidosis, and anaemia (if AKI is prolonged). |
| Decreased appetite (anorexia) | Uraemia and metabolic derangements. |
| Confusion / altered mental status | Uraemic encephalopathy — toxic metabolites cross the blood-brain barrier and disrupt neurotransmitter function. Also worsened by electrolyte disturbances (hyperkalaemia, hyponatraemia). |
| Dyspnoea | Fluid overload → pulmonary oedema (the kidney cannot excrete water/sodium); metabolic acidosis → compensatory Kussmaul breathing. |
| Peripheral oedema | Fluid retention from ↓ GFR and inability to excrete sodium and water. |
| Muscle cramps | Electrolyte disturbances (especially hypocalcaemia, hyperkalaemia). |
| Flank/back pain | Not typical of ATN per se — if present, consider renal vein thrombosis, obstruction, or other causes. |
| Dark (cola-coloured) urine | Myoglobinuria (rhabdomyolysis) or haemoglobinuria (haemolysis) — the pigment is filtered but not reabsorbed. |
| Sign | Pathophysiological Basis |
|---|---|
| Oliguria (< 0.5 mL/kg/h or < 500 mL/day) | Decreased GFR from mechanisms described above. Oliguric phase is the hallmark [2]. |
| Polyuria (in non-oliguric ATN or recovery phase — up to 3 L/day) | Tubular cells cannot concentrate urine; osmotic diuresis from accumulated solutes [2][8]. |
| Hypertension | Volume overload — the kidney cannot excrete sodium and water, leading to expanded ECF volume → ↑ preload → ↑ BP. |
| Peripheral oedema, pulmonary crepitations | Fluid overload → interstitial oedema (peripheral) and pulmonary oedema (crepitations on auscultation). |
| Elevated JVP | Reflects volume overload and raised central venous pressure. |
| Signs of underlying cause | E.g., hypotension/tachycardia (shock), abdominal tenderness (pancreatitis/rhabdomyolysis), surgical wounds, septic features (fever, rigors). |
| Signs of uraemia (if AKI prolonged) | Uraemic frost (rare, white crystalline deposits on skin), pericardial friction rub (uraemic pericarditis), asterixis (flapping tremor), altered consciousness. |
| Metabolic acidosis | ↓ ability to excrete H⁺ and regenerate HCO₃⁻ → high anion gap metabolic acidosis (retention of sulphates, phosphates, and organic acids normally cleared by the kidney) [2]. |
| Hyperkalaemia | ↓ renal excretion of K⁺ [2]. Dangerous — can cause cardiac arrhythmias (peaked T waves, widened QRS, sine wave → cardiac arrest). K⁺ > 6 mmol/L requires urgent treatment [1]. |
| Hyponatraemia | Dilutional — water retention exceeds sodium retention. |
| Hypocalcaemia | ↓ 1,25-dihydroxyvitamin D production (1-alpha hydroxylation occurs in the PCT — damaged in ATN), hyperphosphataemia (phosphate binds calcium), and skeletal resistance to PTH. Particularly prominent in rhabdomyolysis-associated ATN. |
| Hyperphosphataemia | ↓ renal phosphate excretion; also released from damaged muscle cells in rhabdomyolysis and from tumour lysis. |
| Context | Additional Features |
|---|---|
| Post-surgical ATN | Oliguria noted in the first 24–72 hours post-op; often ischaemic from intraoperative hypotension or haemorrhage. |
| Aminoglycoside ATN | Non-oliguric initially; preceded by polyuria and tubular dysfunction [6][8]. Onset typically 5–10 days after starting the drug. Monitor creatinine daily. |
| Contrast nephropathy | Cr rises 24–48 hours after contrast exposure; peaks at 3–5 days; returns to baseline by 7–14 days [1]. Usually mild. |
| Rhabdomyolysis ATN | Dark urine (myoglobinuria), severe muscle pain, markedly elevated CK (> 5× ULN, often > 10,000 IU/L), dipstick +ve for blood but microscopy –ve for RBCs [11]. Hyperkalaemia, hyperphosphataemia, hypocalcaemia, high AG metabolic acidosis. |
| Sepsis-associated ATN | Part of multi-organ dysfunction syndrome (MODS) [12]. AKI often accompanies ARDS, DIC, and hepatic dysfunction. |
| Tumour lysis ATN | Hyperuricaemia, hyperkalaemia, hyperphosphataemia, hypocalcaemia. Crystal deposition in tubules. |
Exam Tip - Urine Findings in ATN
The presence of "muddy brown casts" (granular casts) and free renal tubular epithelial cells on urinalysis is pathognomonic for ATN [1][2]. This is because damaged tubular cells slough off, mix with Tamm-Horsfall protein, and form these characteristic casts. This finding alone can clinch the diagnosis on a written exam.
FENa is typically > 2% in ATN (the damaged tubules cannot reabsorb sodium), versus < 1% in prerenal disease (tubules are intact and avidly reabsorbing sodium in response to hypoperfusion) [1].
Exception: Contrast nephropathy has FENa < 1% because the predominant mechanism is vasoconstriction, not pure tubular necrosis [1].
This is a critical clinical question — the management is very different.
| Parameter | Prerenal AKI | ATN (Intrinsic) |
|---|---|---|
| Urine output | Oliguria (concentrated) | Oliguric or non-oliguric |
| Urine specific gravity | > 1.020 (concentrated) | < 1.010 (isosthenuric — cannot concentrate) |
| Urine osmolality | > 500 mOsm/kg | < 350 mOsm/kg |
| FENa | < 1% | > 2% [1] |
| FEUrea | < 35% | > 50% |
| Urine Na⁺ | < 20 mmol/L | > 40 mmol/L |
| BUN:Cr ratio | > 20:1 (disproportionate urea rise) | 10–15:1 |
| Urine sediment | Bland, occasional hyaline casts | Muddy brown granular casts, epithelial cell casts, free tubular cells [1] |
| Response to fluids | Improves with volume resuscitation | Does NOT improve with fluids (may worsen with fluid overload) |
Why is BUN:Cr elevated in prerenal? In prerenal states, low flow through the kidney allows more time for urea reabsorption in the collecting duct (urea follows water passively). Creatinine is not reabsorbed, so the BUN:Cr ratio rises disproportionately.
Why is FENa low in prerenal? The tubules are intact and functioning normally — in response to low perfusion, the RAAS is activated → aldosterone promotes maximal Na⁺ reabsorption → very little Na⁺ appears in the urine.
| Investigation | Expected Finding in ATN |
|---|---|
| Serum creatinine | Rising (defines AKI by KDIGO criteria) |
| Urine R/M | Muddy brown granular casts, epithelial cell casts, free renal tubular epithelial cells [1] |
| FENa | > 2% (except contrast nephropathy: < 1%) [1] |
| Urine osmolality | < 350 mOsm/kg (isosthenuric) |
| Urine Na⁺ | > 40 mmol/L |
| Histology | Severe tubular disruption with sloughing of tubular cells; rarification then disappearance of brush border; enlarged lysosomes with myeloid bodies; mitochondrial swelling; tubular necrosis; regeneration [1][6] |
| CK | Markedly elevated if rhabdomyolysis |
| Renal USS | Normal-sized kidneys (unlike CKD where kidneys are small); r/o obstruction |
High Yield Summary
- ATN = most common cause of intrinsic AKI in hospitalised patients.
- Two major causes: Ischaemic (progression of prerenal failure) and Nephrotoxic (aminoglycosides, cisplatin, contrast, myoglobin, etc.).
- Most vulnerable segments: S3 segment of PCT and thick ascending limb of Loop of Henle in the outer medulla — high metabolic demand, borderline O₂ supply.
- Pathophysiology chain: ATP depletion → loss of cell polarity → brush border loss → cell necrosis/apoptosis → sloughing → cast formation → tubular obstruction + backleak + TGF activation → ↓ GFR.
- Clinical phases: Oliguric phase (↓ urine, ↑ urea, metabolic acidosis, hyperkalaemia) → Diuretic phase (up to 3 L/day, risk of dehydration/hypokalaemia) → Recovery.
- Pathognomonic finding: "Muddy brown granular casts" on urinalysis.
- FENa > 2% in ATN vs < 1% in prerenal (exception: contrast nephropathy FENa < 1%).
- Non-oliguric ATN: aminoglycosides and cisplatin — creatinine rises but urine output normal/increased due to impaired tubular concentrating ability.
- Aminoglycoside histopathology: rarification then disappearance of brush border; enlarged lysosomes with myeloid bodies; mitochondrial swelling; tubular necrosis; regeneration.
- Contrast nephropathy: Cr rises 24–48h post-contrast, peaks 3–5 days, resolves 7–14 days. Prevention: avoid if eGFR < 30, use NAC + IV hydration.
Active Recall - Acute Tubular Necrosis
[1] Senior notes: Adrian Lui Pediatrics Notes.pdf (Acute tubular necrosis section, p.331) [2] Senior notes: Block A - Nephrotology Teaching Clinic RTD.pdf (Acute Tubular Injury section, pp.1–7) [3] Senior notes: learning_points_output.txt (Nephrology — AKI learning points) [4] Senior notes: Block A - Glomerular and Tubulo-interstitial Diseases and Acute Kidney Injury.pdf (AKI Aetiology, pp.34–35) [5] Senior notes: Ryan Ho Critical Care.pdf (AKI and Renal Support, p.25) [6] Lecture slides: GC 043. Drugs and the Kidney.pdf (Aminoglycosides slide, p.20) [7] Senior notes: Block A - Glomerular and Tubulo-interstitial Diseases and Acute Kidney Injury.pdf (Tubulointerstitial diseases, p.29) [8] Senior notes: Block A - Drugs and the Kidney.pdf (Aminoglycosides section, p.10) [9] Senior notes: Block A - Chronic Kidney Disease and its Complications.pdf (Drug-induced kidney disease, pp.11–12) [10] Senior notes: Block A – Nephrology Data Interpretation.pdf (Case 3 — NSAIDs and renal impairment, p.11) [11] Senior notes: Ryan Ho Neurology.pdf (Rhabdomyolysis section, p.196) [12] Senior notes: MBBS Final MB (Surgery) (Felix PY Lai).pdf (Sepsis — MODS, p.36)
Differential Diagnosis of Acute Tubular Necrosis
When you see a patient with rising creatinine ± oliguria — i.e., the clinical picture of AKI — your first job is not to jump straight to ATN. You must systematically work through the differential diagnosis. ATN is just one cause of intrinsic renal AKI, which itself is just one of three major categories. The differential diagnosis of ATN therefore operates on two levels:
- Level 1: Distinguishing ATN from other causes of AKI (prerenal, other intrinsic renal, post-renal)
- Level 2: Once you suspect intrinsic renal AKI, distinguishing ATN from other intrinsic causes (AIN, glomerulonephritis, vascular)
Every patient with AKI must be classified into one of these three anatomical compartments [5][4]. This is the fundamental first step before you can diagnose ATN.
Pre-renal causes account for > 1/2 of all AKI, intrinsic renal causes for < 1/2, and post-renal (obstructive) causes for < 10% [4][5]. Recognizing pre- and post-renal disease is particularly important because these are often rapidly reversible compared to renal intrinsic disease [5].
Prolonged pre-renal and post-renal disease will progress to become ATN and tubulointerstitial fibrosis respectively, i.e. intrinsic renal disease [5]. This is a critical concept — prerenal AKI left untreated becomes ischaemic ATN.
This is the single most commonly tested differential in nephrology exams. Both prerenal AKI and ischaemic ATN exist on a continuum — prerenal is the "functional" phase (intact tubules, reversible with fluids), while ATN is the "structural" phase (tubular damage, not reversible with fluids alone) [4][5].
Why does this distinction matter clinically?
- Prerenal AKI: Give fluids → kidney recovers.
- ATN: Giving fluids won't fix the damaged tubules and may cause dangerous fluid overload (pulmonary oedema, heart failure).
| Feature | Prerenal AKI | ATN |
|---|---|---|
| Pathology | Hypoperfusion with intact tubules | Tubular cell necrosis/injury |
| Reversibility | Rapidly reversible with volume/perfusion restoration | Not immediately reversible; requires time for tubular regeneration |
| Urine output | Oliguria (concentrated urine) | Oliguric or non-oliguric |
| Urine osmolality | > 500 mOsm/kg | < 350 mOsm/kg (isosthenuric) |
| Urine Na⁺ | < 20 mmol/L | > 40 mmol/L |
| FENa | < 1% | > 2% (> 3% per some sources) [2][13] |
| FEUrea | < 35% | > 50% |
| BUN:Cr ratio | > 20:1 | 10–15:1 |
| Urine sediment | Bland (hyaline casts only) | Muddy brown granular casts, epithelial cell casts, free renal tubular epithelial cells [1][2] |
| Response to IV fluids | Creatinine improves within 24–48h | No improvement; creatinine continues to rise or plateaus |
Why is BUN:Cr disproportionately elevated in prerenal? In low-flow states, urea has more time for passive reabsorption in the collecting duct (it follows water under ADH influence). Creatinine is neither reabsorbed nor secreted significantly, so urea rises out of proportion → high BUN:Cr ratio.
Why is FENa low in prerenal? The tubular cells are intact and functioning optimally. RAAS activation (from hypoperfusion) → aldosterone → maximal Na⁺ reabsorption in the collecting duct → almost no Na⁺ escapes into the urine → FENa < 1%.
Why is FENa high in ATN? The tubular cells are dead or dysfunctional — they physically cannot reabsorb sodium regardless of aldosterone stimulation → sodium "leaks" into the urine → FENa > 2%.
Important Exception
Contrast nephropathy has FENa < 1% despite being classified as ATN [1]. This is because the predominant mechanism is renal vasoconstriction (functionally similar to prerenal) rather than pure tubular necrosis. Similarly, early sepsis-associated AKI, myoglobinuric AKI (before established necrosis), and NSAID-related AKI can all have FENa < 1% initially. Also, patients on diuretics will have artificially elevated FENa even in prerenal states — in these patients, use FEUrea instead (< 35% suggests prerenal).
3. Intrinsic Renal Causes — Differentiating ATN from Other Intrinsic Pathologies
Once you've determined the AKI is intrinsic (not prerenal, not post-renal), you need to distinguish ATN from the other intrinsic renal diseases. Think of this anatomically — which compartment of the kidney is affected?
This is the second most important differential because both are tubulointerstitial diseases and can be drug-related.
| Feature | ATN | AIN |
|---|---|---|
| Mechanism | Direct tubular cell death (ischaemia or toxin) | Immune-mediated interstitial inflammation (hypersensitivity) |
| Onset of RFT decline | Minutes (ischaemic) or days (nephrotoxic) [14] | Days (typically 7–14 days after offending drug) [14] |
| Classic triad | None | Fever + Eosinophilia + Rash (but only in ~10% of cases) [2][15] |
| Urine sediment | Muddy brown granular casts [1][2] | WBC casts, sterile pyuria, eosinophiluria [1][16] |
| Proteinuria | Mild (tubular — low molecular weight) | Mild-moderate; nephrotic-range proteinuria rare except in NSAID-induced AIN (where concurrent MCD can occur) [17] |
| Eosinophilia | Absent | Present in ~40% of NSAID-induced cases [17] |
| Common drug causes | Aminoglycosides, cisplatin, contrast, amphotericin B | Penicillins, allopurinol, rifampicin, diuretics, omeprazole (PPIs), NSAIDs [9][17] |
| Renal biopsy | Tubular necrosis, loss of brush border | Interstitial inflammatory infiltrate (lymphocytes ± eosinophils), tubular injury without prominent necrosis |
| Treatment | Supportive (remove cause, fluids) | Remove offending drug ± corticosteroids |
"Absence of hypersensitivity manifestation with ATN; absence of pyuria in AIN" — this is how Felix Lai summarises the key distinguishing feature [15]. In practice: if you see fever + rash + eosinophilia + rising creatinine after starting a new drug → think AIN. If you see rising creatinine with muddy brown casts after haemodynamic instability or a known nephrotoxin → think ATN.
High Yield - NSAID-Induced Nephrotic Syndrome + AKI
NSAIDs can simultaneously cause minimal change glomerulonephropathy (at the glomerulus) and acute tubulointerstitial nephritis (at the tubules) [17]. This presents as nephrotic syndrome + AKI with eosinophilia, higher risk in elderly [17]. The renal biopsy classically shows MCD in the glomerulus and AIN in the tubulointerstitium [17]. This is distinct from ATN — there is no tubular necrosis per se, but rather immune-mediated inflammation.
PPIs are known to cause acute tubulointerstitial nephritis → AKI, and chronic tubulointerstitial nephritis → CKD [9]. PD-1 inhibitors also cause acute tubulointerstitial nephritis → AKI [9].
| Feature | ATN | Acute GN / RPGN |
|---|---|---|
| Mechanism | Tubular cell death | Glomerular inflammation (immune complex, anti-GBM, pauci-immune) |
| Urine sediment | Muddy brown granular casts | Dysmorphic RBCs, RBC casts [1] — pathognomonic for glomerular bleeding |
| Proteinuria | Mild (tubular) | Moderate-heavy (glomerular — albumin predominant) |
| Haematuria | Absent or minimal | Prominent — active sediment |
| Systemic features | Related to underlying cause (shock, sepsis) | Often has systemic disease features: rash (SLE, vasculitis), haemoptysis (anti-GBM → Goodpasture syndrome, ANCA vasculitis), arthralgia, sinus disease (GPA) |
| Serology | Usually negative | ASLO, ANA, anti-dsDNA, C3/4, anti-GBM, ANCA [1] |
| Speed of decline | Variable | RPGN: creatinine can double within days to weeks ("rapidly progressive") |
| Renal biopsy | Tubular necrosis | Crescents (RPGN), mesangial proliferation, immune complex deposition |
Key clinical clue: If you see RBC casts in the urine → the pathology is glomerular, not tubular. RBC casts form when blood leaks across an inflamed glomerular basement membrane, enters the tubular lumen, and gets trapped in a Tamm-Horsfall protein matrix. You will never see RBC casts in ATN (the glomerulus is structurally intact in ATN — the problem is downstream in the tubules).
| Feature | ATN | Vascular AKI |
|---|---|---|
| Thrombotic microangiopathy (TMA) — TTP/HUS | ATN can be secondary to TMA | Microangiopathic haemolytic anaemia (MAHA): schistocytes on blood film, ↑LDH, ↑reticulocytes, ↓haptoglobin, thrombocytopenia. TTP: pentad of MAHA + thrombocytopenia + AKI + neurological symptoms + fever. HUS: MAHA + thrombocytopenia + AKI (especially post-diarrhoea in children — Shiga toxin). |
| Renal artery stenosis (RAS) | Not RAS | Secondary/resistant hypertension with hypokalaemia, flash pulmonary oedema, AKI especially after starting ACEI [14]. Duplex Doppler USG for screening, angiogram for confirmation. |
| Atheroembolic disease ("cholesterol crystal embolism") | Not atheroembolic | Occurs after vascular procedures (catheterisation, vascular surgery). Blue toe syndrome, livedo reticularis, eosinophilia, hypocomplementaemia. Renal biopsy shows cholesterol clefts. |
| Malignant hypertension | Not malignant HT | Severely elevated BP (typically > 200/120), papilloedema, retinal haemorrhages, encephalopathy, MAHA. |
| Vasculitis | ATN can occur secondary to vasculitis | ANCA-positive (GPA, MPA, EGPA) or anti-GBM. Systemic features: pulmonary haemorrhage, sinusitis, skin purpura. |
| Feature | ATN | Myeloma Cast Nephropathy |
|---|---|---|
| Mechanism | Tubular cell death from ischaemia/toxin | Monoclonal immunoglobulin light chains precipitate in tubules → form waxy casts that obstruct and directly injure tubular cells [2] |
| Demographics | Any age | Typically elderly (> 60) with bone pain, anaemia, hypercalcaemia |
| Urine | Muddy brown casts | Waxy casts; Bence Jones proteinuria (light chains — not detected on standard dipstick which detects albumin only) |
| Key investigations | FENa, urine sediment | Serum protein electrophoresis, serum free light chains, urine Bence Jones protein, bone marrow biopsy |
| Clue | Context of shock/nephrotoxins | "An old man with bone pain and anaemia" — classic HKUMed presentation [18] |
Post-renal obstruction must always be excluded because it is rapidly reversible with decompression.
| Feature | ATN | Post-renal Obstruction |
|---|---|---|
| Mechanism | Tubular necrosis | Physical obstruction to urine outflow → back-pressure → ↓ GFR |
| Bilateral requirement | N/A | Must be bilateral (or unilateral in a solitary kidney) to cause AKI [5] |
| Common causes | N/A | BPH, CA prostate, bladder neck tumour, urinary stones, retroperitoneal fibrosis [5] |
| Renal USS | Normal-sized kidneys, no hydronephrosis | Hydronephrosis (dilated pelvicalyceal system) |
| Urine output pattern | Oliguria or non-oliguric | May be anuric (complete obstruction) or have fluctuating output |
| Post-obstructive diuresis | Not applicable | After relief of obstruction, massive polyuria can occur |
In patients with liver cirrhosis who develop AKI, you must distinguish between prerenal AKI, ATN, and hepatorenal syndrome (HRS) [19].
| Feature | Prerenal | ATN | HRS |
|---|---|---|---|
| Mechanism | Hypovolaemia (GI bleed, diuretics) | Tubular necrosis (ischaemia, nephrotoxins) | Functional renal vasoconstriction in setting of splanchnic vasodilation and ↓ effective circulating volume |
| FENa | < 1% | > 2% | < 1% (tubules intact, avidly reabsorbing Na) |
| Urine sediment | Bland | Muddy brown casts | Bland |
| Response to albumin challenge | Improves | No improvement | No improvement (by definition — HRS is diagnosed only after failure of volume expansion) |
| Prognosis | Good if corrected | Moderate | Poor prognostic marker → patient may be dead in the coming future [19] |
In the context of renal transplantation, oliguria/anuria in the post-operative period has a specific differential [20]:
- Acute allograft rejection
- Acute vascular (arterial or venous) thrombosis
- Acute tubular necrosis (from ischaemia during procurement/transplantation — "post-ischaemic ATN")
- Obstructive uropathy (ureteric kink, clot)
- Urinary leakage (ureteral necrosis, bladder injury)
- Acute cyclosporin A or tacrolimus toxicity [20]
Investigation: Urgent Duplex USG kidney + consider renal biopsy + MAG-3/DTPA scan [20].
This is extremely high yield for exams. The urine sediment is your best friend for narrowing the differential.
| Urine Finding | Suggests |
|---|---|
| Muddy brown granular casts + free renal tubular epithelial cells | ATN [1][2] |
| WBC casts, sterile pyuria ± eosinophiluria | AIN [1][16] |
| Dysmorphic RBCs + RBC casts | Glomerulonephritis [1] |
| Hyaline casts only (bland sediment) | Prerenal AKI or HRS |
| Crystals (uric acid, calcium oxalate) | Crystal nephropathy, tumour lysis |
| Waxy casts | Myeloma cast nephropathy |
| Dipstick +ve blood, microscopy –ve RBCs | Myoglobinuria (rhabdomyolysis) or haemoglobinuria [11] |
High Yield Summary
- The first step in any AKI is to classify into prerenal ( > 50%), intrinsic renal ( < 50%), post-renal ( < 10%) [4][5].
- Prerenal vs ATN is the most important differential: FENa < 1% = prerenal; FENa > 2% = ATN (exception: contrast nephropathy FENa < 1%) [1][13].
- Muddy brown granular casts = ATN; WBC casts + sterile pyuria = AIN; RBC casts = GN; bland sediment = prerenal or HRS [1][2].
- AIN classic triad: fever + eosinophilia + rash (only ~10%). Key drugs: penicillins, allopurinol, rifampicin, PPIs, NSAIDs [2][9][17].
- NSAIDs can cause ATN (via ↓ prostaglandins → ↓ renal perfusion), AIN, and nephrotic syndrome (MCD + AIN) — a single drug, three mechanisms [9][17].
- Always exclude post-renal obstruction with renal USS — it is rapidly reversible [5].
- Prolonged prerenal AKI → ischaemic ATN; prolonged post-renal obstruction → tubulointerstitial fibrosis — both become intrinsic disease if not corrected [5].
- In post-transplant setting, ATN differential includes acute rejection, vascular thrombosis, CsA/tacrolimus toxicity, ureteric obstruction, urinary leak [20].
Active Recall - Differential Diagnosis of ATN
References
[1] Senior notes: Adrian Lui Pediatrics Notes.pdf (Acute tubular necrosis section, p.331) [2] Senior notes: Block A - Nephrotology Teaching Clinic RTD.pdf (Acute Tubular Injury section, pp.1–8) [4] Senior notes: Block A - Glomerular and Tubulo-interstitial Diseases and Acute Kidney Injury.pdf (AKI Aetiology, pp.34–35) [5] Senior notes: Ryan Ho Critical Care.pdf (AKI and Renal Support, p.25) [6] Lecture slides: GC 043. Drugs and the Kidney.pdf (Aminoglycosides slide, p.20) [8] Senior notes: Block A - Drugs and the Kidney.pdf (Aminoglycosides section, p.10) [9] Senior notes: Block A - Chronic Kidney Disease and its Complications.pdf (Drug-induced kidney disease, pp.11–12) [11] Senior notes: Ryan Ho Neurology.pdf (Rhabdomyolysis section, p.196) [13] Senior notes: Block A - Nephrotology Teaching Clinic RTD.pdf (Diagnosis of ATN — FENa section, p.8) [14] Senior notes: Maksim Medicine Notes.pdf (Tubulointerstitial nephritis, p.234) [15] Senior notes: MBBS Final MB (Medicine) (Felix PY Lai).pdf (AIN differential diagnosis, p.1028) [16] Senior notes: MBBS Final MB (Pediatrics) (Felix PY Lai).pdf (Urine sediment interpretation, p.418) [17] Senior notes: Block A - Drugs and the Kidney.pdf (NSAID-induced nephrotic syndrome + AKI, p.14) [18] Lecture slides: GC 030. An old man with bone pain and anaemia.pdf [19] Senior notes: Block A - Abdominal distension_ ascites and cirrhosis.pdf (AKI in liver disease + HRS, p.20) [20] Senior notes: MBBS Final MB (Surgery) (Felix PY Lai).pdf (Renal transplant complications — oliguria/anuria, pp.886–888)
Diagnostic Criteria, Diagnostic Algorithm, and Investigations for Acute Tubular Necrosis
1. Diagnostic Criteria
ATN does not have its own standalone diagnostic criteria in the way that, say, SLE or rheumatoid arthritis does. Instead, the diagnosis of ATN is made in two steps:
- Step 1: Confirm that the patient has Acute Kidney Injury (using KDIGO criteria)
- Step 2: Determine that the cause of AKI is intrinsic renal tubular injury (using clinical context, urinalysis, and biochemical indices — and sometimes renal biopsy)
| Stage | Serum Creatinine | Urine Output |
|---|---|---|
| I | 1.5–1.9× baseline within 7 days or ≥ 26.5 µmol/L rise in 48h | < 0.5 mL/kg/h for 6–12 hours |
| II | 2.0–2.9× baseline within 7 days | < 0.5 mL/kg/h for ≥ 12 hours |
| III | ≥ 3.0× baseline within 7 days or initiation of RRT | < 0.3 mL/kg/h for ≥ 24 hours or anuria ≥ 12 hours |
Other AKI classification systems: AKIN and RIFLE (RIFLE is used mainly in ICU settings) [21]. KDIGO is the most commonly used in Hong Kong [21].
- Insensitive for early AKI: GFR already ↓ 50% when creatinine rises [14]
- Not useful if patient is on dialysis (creatinine is removed by dialysis) [14]
- Affected by muscle mass, diet, drugs (e.g. trimethoprim blocks tubular creatinine secretion → falsely elevated)
- Newer biomarkers such as NGAL (neutrophil gelatinase-associated lipocalin), KIM-1, and IL-18 can detect tubular injury earlier but are not routine [21]
Once AKI is confirmed, the diagnosis of ATN rests on:
| Criterion | Detail |
|---|---|
| Clinical context | Identifiable ischaemic or nephrotoxic insult (e.g. recent hypotension, sepsis, aminoglycoside use, contrast exposure) |
| Urine sediment | Muddy brown granular casts and/or epithelial cell casts + free renal tubular epithelial cells — pathognomonic [1][2] |
| FENa | > 2% (some sources say > 3%) in typical ATN [1][2][13] |
| Exclusion of prerenal | No improvement with adequate fluid resuscitation |
| Exclusion of post-renal | No hydronephrosis on renal USS |
| Exclusion of other intrinsic causes | No RBC casts (GN), no drug hypersensitivity triad (AIN), no MAHA features (TMA) |
"Diagnosis is made by a FENa > 3% and presence of muddy casts in urinalysis" [13]. "On histopathology, there is usually tubulorrhexis, that is, localized necrosis of the epithelial lining in renal tubules, with focal rupture or loss of basement membrane" [13].
ATN is Usually a Clinical Diagnosis
In practice, most cases of ATN are diagnosed clinically — by the clinical context (shock, nephrotoxin exposure) + characteristic urinalysis (muddy brown casts) + FENa > 2% + failure to respond to fluids. Renal biopsy is reserved for cases where the cause of AKI is unclear, or when ATN does not recover as expected [1]. Consider biopsy if persistent oliguria > 6 weeks [14].
The algorithm below shows the systematic approach to a patient with AKI, leading to the diagnosis of ATN. The philosophy is: exclude the reversible causes first (post-renal obstruction, then prerenal hypovolaemia), then characterise the intrinsic cause.
3. Investigation Modalities — Detailed Breakdown
Let's go through every investigation systematically, explaining what you're looking for, why you're ordering it, and how to interpret it in the context of ATN.
3.1 Bedside Investigations
- What: Strict hourly I/O charting with indwelling catheter if needed.
- Why: Urine output is one of the two KDIGO criteria for AKI. It also helps stage AKI severity and distinguish oliguric from non-oliguric ATN.
- Interpretation:
- Oliguria: < 0.5 mL/kg/h for ≥ 6 hours [21] → classic for ischaemic ATN
- Anuria: < 50 mL/day → think of complete urinary obstruction, bilateral renal artery occlusion, acute cortical necrosis, or RPGN [14]
- Normal/high urine output with rising creatinine → non-oliguric ATN (aminoglycosides, cisplatin) [6][8]
- What: Daily weights, JVP assessment, peripheral oedema, lung auscultation, skin turgor, mucous membranes.
- Why: To assess volume status — critical for distinguishing prerenal (hypovolaemic) from ATN (euvolaemic/hypervolaemic) and guiding fluid therapy.
- What: Bedside semiquantitative test for protein, blood, leucocytes, nitrites, glucose, pH, specific gravity.
- Interpretation in ATN:
- Blood: May be mildly positive (from tubular cells, not glomerular bleeding). If strongly positive for blood but microscopy shows no RBCs → suspect myoglobinuria (rhabdomyolysis) or haemoglobinuria [11].
- Protein: Usually mildly positive (tubular proteinuria — low molecular weight proteins like β₂-microglobulin, not albumin).
- Specific gravity: Low (< 1.010) — isosthenuric, reflecting loss of concentrating ability.
- What: 12-lead ECG
- Why: To assess for hyperkalaemia — a life-threatening complication of ATN.
- Findings: Peaked T waves → flat P waves → widened QRS → sine wave → VF/asystole. HyperK > 6 mmol/L requires urgent treatment [1].
3.2 Blood Investigations
| Component | Normal Range | Expected in ATN | Interpretation |
|---|---|---|---|
| Serum creatinine | 65–100 µmol/L | Elevated (rising pattern) | Confirms AKI. Rate of rise helps gauge severity. |
| Urea | 2.5–7.8 mmol/L | Elevated | In prerenal: urea rises disproportionately to creatinine (BUN:Cr > 20:1). In ATN: both rise proportionately (BUN:Cr 10–15:1). |
| eGFR | > 90 mL/min/1.73m² | Decreased | eGFR formulae (CKD-EPI/MDRD) are inaccurate in AKI because they assume steady-state creatinine. Use only as a rough guide in AKI. |
| Sodium | 135–145 mmol/L | May be low (dilutional hyponatraemia from fluid retention) | |
| Potassium | 3.5–5.0 mmol/L | Elevated (hyperkalaemia) | Dangerous — ECG changes, arrhythmias. K⁺ > 6 requires urgent treatment [1]. |
| Chloride | 95–105 mmol/L | Variable |
| Test | Finding | Significance |
|---|---|---|
| Haemoglobin | May be ↓ | Anaemia in CKD (normochromic normocytic), MAHA (TTP/HUS), DIC, haemorrhage [1] |
| Blood film | Schistocytes | MAHA → TTP/HUS/DIC → vascular cause of AKI, not simple ATN [1] |
| WBC | May be ↑ | Infection/sepsis (the cause of ATN) |
| Platelets | May be ↓ | DIC, TTP/HUS, myeloma |
| Clotting (PT/APTT) | May be prolonged | DIC, liver disease (hepatorenal syndrome) [1] |
| Eosinophils | If elevated | Consider AIN (not ATN) — eosinophilia is 23% of AIN cases [2] |
| Test | Expected in ATN | Why |
|---|---|---|
| Hyperkalaemia | ↑ K⁺ | ↓ renal excretion + cellular release (especially in rhabdomyolysis/haemolysis) |
| Hypocalcaemia | ↓ Ca²⁺ | ↓ 1,25-dihydroxyvitamin D production in damaged PCT; hyperphosphataemia binds Ca²⁺; Ca²⁺ sequestration in damaged muscles (rhabdomyolysis) |
| Hyperphosphataemia | ↑ PO₄³⁻ | ↓ renal excretion; release from damaged cells (rhabdomyolysis, tumour lysis) |
| Metabolic acidosis | ↓ HCO₃⁻, ↑ AG | ↓ H⁺ excretion, ↓ HCO₃⁻ regeneration; accumulation of organic acids (sulphates, phosphates, lactate) |
| Finding | Significance |
|---|---|
| Hypoalbuminaemia | Nephrotic syndrome (if concurrent glomerular disease), liver disease (hepatorenal syndrome) [1] |
| ↑ Bilirubin | Haemolysis, hepatic disease |
| ↑ AST/ALT | Rhabdomyolysis (AST/ALT released from damaged muscle — but predominantly from liver; CK is more specific for muscle) |
This is ordered not to diagnose ATN, but to exclude glomerulonephritis and vasculitis [1]:
| Test | Disease Excluded |
|---|---|
| ASLO | Post-streptococcal GN |
| ANA, anti-dsDNA | Lupus nephritis |
| C3/C4 | Complement-consuming GN (MPGN, PSGN, lupus, cryoglobulinaemia) |
| ANCA | ANCA-associated vasculitis (GPA, MPA, EGPA) |
| Anti-GBM | Anti-GBM disease (Goodpasture syndrome) |
| HBsAg, anti-HCV | Hepatitis-associated GN |
| Immunoglobulin pattern | Multiple myeloma (paraprotein), IgA nephropathy |
| Serum free light chains + SPEP | Myeloma cast nephropathy [24] |
3.3 Urine Investigations — The Cornerstone of ATN Diagnosis
This is the single most important investigation for diagnosing ATN.
"The presence of 'muddy brown casts' of epithelial cells found in the urine during urinalysis is pathognomonic for ATN" [2].
| Finding | Description | Significance |
|---|---|---|
| Muddy brown granular casts | Degranulated tubular cell debris within a Tamm-Horsfall protein matrix; appear as dark, coarsely granular cylinders | Pathognomonic for ATN [1][2][16]. Formed from sloughed necrotic tubular cells that aggregate with uromodulin (Tamm-Horsfall protein). |
| Renal tubular epithelial cell casts | Intact tubular cells embedded in a cast matrix | Desquamation of the tubular epithelium — ATN, AIN, or proliferative GN [16] |
| Free renal tubular epithelial cells | Individual rounded cells with a large nucleus, found loose in urine | Sloughing of tubular cells into urine [1] — due to loss of cell adhesion after ischaemic/toxic injury |
| Hyaline casts | Transparent casts of pure Tamm-Horsfall protein | Non-specific — can be seen in normal urine, concentrated urine, or prerenal AKI. NOT diagnostic of ATN. |
| RBC casts | RBCs embedded in a cast matrix | Absent in ATN → suggests glomerulonephritis [1][16] |
| WBC casts | WBCs embedded in a cast matrix | Not typical of ATN → suggests AIN [16] |
Tamm-Horsfall Protein — The Cast Matrix
Casts have an organic matrix composed primarily of Tamm-Horsfall mucoprotein [25], which is normally secreted by cells of the thick ascending limb of the Loop of Henle. It normally prevents UTI by binding to uropathogenic bacteria. In pathological states, this protein polymerizes in the tubular lumen and traps whatever cells/debris are present — forming the various types of casts. The type of cast tells you what was in the tubule at the time of formation.
This is the gold-standard biochemical test for distinguishing prerenal AKI from ATN.
Formula:
Where:
- U_Na = urine sodium concentration
- P_Cr = plasma creatinine concentration
- P_Na = plasma sodium concentration
- U_Cr = urine creatinine concentration
Interpretation:
| FENa | Interpretation | Mechanism |
|---|---|---|
| < 1% | Prerenal AKI (or contrast nephropathy, HRS, early sepsis) | Tubules intact → avidly reabsorbing Na⁺ under RAAS stimulation |
| > 2% (or > 3%) | ATN | Tubules damaged → cannot reabsorb Na⁺ regardless of RAAS activation |
Why the cut-offs work: In prerenal AKI, the kidney "thinks" it is being underperfused, so it activates the RAAS → aldosterone tells the collecting duct to maximally reabsorb Na⁺ → almost zero Na⁺ in the urine → FENa very low. In ATN, the tubular cells are dead — they cannot respond to aldosterone's signal → Na⁺ pours into the urine → FENa high.
When FENa Misleads
- Diuretics increase urinary Na⁺ excretion even in prerenal states → FENa falsely elevated. Use FEUrea instead (< 35% = prerenal, > 50% = ATN) — urea handling is not affected by diuretics.
- Contrast nephropathy: FENa < 1% because predominant mechanism is vasoconstriction [1].
- Early sepsis-associated AKI: FENa may be < 1% initially (haemodynamic phase before tubular injury sets in).
- Myoglobinuric AKI: FENa may be < 1% early on.
| Test | Prerenal | ATN |
|---|---|---|
| Urine Na⁺ | < 20 mmol/L | > 40 mmol/L |
| Urine osmolality | > 500 mOsm/kg (concentrated — tubules working) | < 350 mOsm/kg (isosthenuric — tubules cannot concentrate) |
| Urine/plasma creatinine ratio | > 40 | < 20 |
| Urine/plasma urea ratio | > 20 | < 10 |
| Plasma urea/creatinine ratio | > 100 | < 40 |
- Why: To exclude UTI as a cause of sterile pyuria or as a contributing factor to sepsis-induced ATN [1].
3.4 Imaging
Renal USS is done in virtually all AKI patients to rule out obstructive causes [1].
| Finding | Interpretation |
|---|---|
| Normal-sized kidneys, normal echotexture | Supports AKI (not CKD — where kidneys are typically small) |
| Hydronephrosis | Post-renal obstruction — not ATN |
| Loss of corticomedullary differentiation (whitening) | More chronic change — suggests CKD rather than acute ATN [21] |
| Increased echogenicity | Non-specific — can be seen in ATN, AIN, CKD |
| Cysts | PCKD or simple cysts — not ATN |
| Doppler: increased resistive index | Seen in ATN (intrarenal vasoconstriction) but non-specific |
| Finding | Significance |
|---|---|
| Pulmonary oedema (fluid overload) | Consequence of ATN → inability to excrete water and sodium |
| Bat-wing appearance | Pulmonary oedema (with cardiomegaly → HF; without cardiomegaly → may suggest pulmonary haemorrhage — check DLCO) [1] |
| Pleural effusions | Volume overload |
| Consolidation | Pneumonia → possible sepsis → possible cause of ATN |
3.5 Renal Biopsy
Renal biopsy is not routinely needed for ATN (the diagnosis is usually clinical). It is indicated when:
- No clear cause of AKI is identified [1]
- AKI does not recover as expected (persistent oliguria > 4–6 weeks) [14]
- Features suggest alternative intrinsic cause (active sediment suggesting GN, systemic features of vasculitis/SLE)
- Suspicion of AIN (to confirm and guide steroid therapy)
- Post-transplant setting (to distinguish ATN from rejection) [20]
| Absolute | Relative |
|---|---|
| Contracted kidneys (hard to target, yield only fibrous tissue) | Solitary kidney |
| Large cysts (uncontrollable bleeding) | Coagulopathy (correct first) |
| Solitary kidney (no backup if complication) | Uncontrolled hypertension |
| Uncooperative patient | Anatomical abnormalities |
Histology: severe tubular disruption with sloughing of tubular cells [1].
| Finding | Description |
|---|---|
| Tubulorrhexis | Localized necrosis of the epithelial lining in renal tubules, with focal rupture or loss of basement membrane [13] |
| Loss of brush border | Rarification (reduction in density) then disappearance of the brush border [6][8] |
| Enlarged lysosomes with myeloid bodies | Characteristic of aminoglycoside toxicity — drug accumulates in lysosomes [6][8] |
| Mitochondrial swelling | ATP depletion → mitochondrial dysfunction [6][8] |
| Tubular necrosis | Coagulative necrosis of tubular epithelial cells — especially in PCT (S3 segment) and TAL [6][8] |
| Regeneration | Flattened epithelial cells with hyperchromatic nuclei and mitotic figures — evidence of tubular recovery [6][8] |
| Interstitial oedema | Inflammatory cell infiltration of the interstitium |
| Glomeruli spared | Unlike GN — glomeruli are histologically normal in ATN |
GC Slide - Aminoglycoside Histopathology
Pathology — rarification then disappearance of brush border; enlarged lysosomes with myeloid bodies; mitochondrial swelling; tubular necrosis; regeneration [6]. This is essentially the complete histological lifecycle of aminoglycoside-induced ATN — from initial injury through to recovery. This is directly from the GC 043. Drugs and the Kidney slide and is extremely high yield for the in-house exam.
| Suspected Cause | Investigation | Key Finding |
|---|---|---|
| Rhabdomyolysis | CK, myoglobin, urine dipstick vs microscopy | ↑↑↑ CK (> 5× ULN); dipstick +ve for blood, microscopy –ve for RBCs [11] |
| Haemolysis | LDH, haptoglobin, reticulocyte count, blood film, direct Coombs | ↑ LDH, ↓ haptoglobin, schistocytes (MAHA), spherocytes (autoimmune) |
| Contrast nephropathy | Timing of Cr rise | ↑ Cr 24–48h post-contrast, peaks 3–5 days, resolves 7–14 days; FENa < 1% [1] |
| Multiple myeloma | SPEP, serum free light chains, urine Bence Jones protein, bone marrow biopsy [24] | Paraprotein band on SPEP, abnormal κ:λ ratio, Bence Jones proteinuria |
| Tumour lysis syndrome | Uric acid, phosphate, potassium, calcium, LDH | ↑↑↑ uric acid, ↑ PO₄, ↑ K⁺, ↓ Ca²⁺, ↑ LDH |
| Sepsis | Blood cultures, CRP, procalcitonin, lactate | Positive cultures, ↑ CRP/procalcitonin, ↑ lactate |
| Drug-induced ATN | Drug levels (aminoglycoside trough/peak, vancomycin trough) | Supratherapeutic drug levels |
Here is a practical checklist organized by category:
| Category | Investigations |
|---|---|
| Bedside | Urine output charting, fluid balance, urine dipstick, ECG |
| Blood — Renal | RFT (Na, K, Cl, urea, creatinine, eGFR) |
| Blood — Metabolic | Electrolytes (Ca, PO₄, Mg), venous blood gas (pH, HCO₃⁻, AG) |
| Blood — Haematology | CBC with differential, blood film, clotting (PT/APTT) |
| Blood — Other | CRP (not ESR — falsely +ve in renal failure), LFT, CK (if rhabdomyolysis), LDH, haptoglobin |
| Blood — Serology | ASLO, ANA, anti-dsDNA, C3/4, ANCA, anti-GBM, HBsAg, anti-HCV, Ig pattern (to exclude GN/vasculitis) |
| Urine | R/M (casts!), spot urine Na⁺, urine osmolality, FENa calculation, urine C/ST |
| Imaging | Renal USS (r/o obstruction), CXR (r/o pulmonary oedema) |
| Histology | Renal biopsy (if diagnosis unclear or ATN not recovering) |
| Special | CK (rhabdomyolysis), SPEP/free light chains (myeloma), drug levels (aminoglycosides) |
High Yield Summary
- ATN diagnosis = KDIGO AKI criteria PLUS clinical context PLUS characteristic urinalysis PLUS biochemical indices.
- KDIGO AKI: ↑ Cr ≥ 26.5 µmol/L in 48h, OR ≥ 1.5× baseline in 7 days, OR UO < 0.5 mL/kg/h for ≥ 6h.
- Pathognomonic urine finding: muddy brown granular casts + free renal tubular epithelial cells.
- FENa > 2% = ATN; < 1% = prerenal. Exception: contrast nephropathy FENa < 1%.
- FENa formula: (U_Na × P_Cr) / (P_Na × U_Cr) × 100%. If on diuretics, use FEUrea instead.
- Renal USS: essential to exclude post-renal obstruction. Normal-sized kidneys in ATN; small kidneys suggest CKD.
- Renal biopsy: not routine — indicated if cause unclear, persistent oliguria > 6 weeks, features of GN/vasculitis, or post-transplant setting.
- ATN histopathology: tubulorrhexis, loss of brush border, enlarged lysosomes with myeloid bodies, mitochondrial swelling, necrosis, regeneration.
- Serum Cr is insensitive: GFR already ↓ 50% when Cr first rises. Newer biomarkers (NGAL, KIM-1) detect injury earlier but are not routine.
- Always send serology (ASLO, ANA, ANCA, anti-GBM, C3/4) to exclude GN/vasculitis — not to diagnose ATN, but to exclude its mimics.
Active Recall - Diagnostic Criteria, Algorithm and Investigations for ATN
References
[1] Senior notes: Adrian Lui Pediatrics Notes.pdf (Acute tubular necrosis section, p.331) [2] Senior notes: Block A - Nephrotology Teaching Clinic RTD.pdf (Acute Tubular Injury section, pp.1–9) [6] Lecture slides: GC 043. Drugs and the Kidney.pdf (Aminoglycosides slide, p.20) [8] Senior notes: Block A - Drugs and the Kidney.pdf (Aminoglycosides section, p.10; Cisplatin section, p.12) [9] Senior notes: Block A - Chronic Kidney Disease and its Complications.pdf (Drug-induced kidney disease, pp.11–12) [11] Senior notes: Ryan Ho Neurology.pdf (Rhabdomyolysis section, p.196) [13] Senior notes: Block A - Nephrotology Teaching Clinic RTD.pdf (Diagnosis of ATN — FENa section, p.8) [14] Senior notes: Maksim Medicine Notes.pdf (AKI diagnostic criteria, p.216) [16] Senior notes: MBBS Final MB (Pediatrics) (Felix PY Lai).pdf (Urine sediment — casts, p.418) [20] Senior notes: MBBS Final MB (Surgery) (Felix PY Lai).pdf (Renal transplant complications, pp.886–888) [21] Senior notes: Block A - Introduction to Renal Investigations (RFT, urine tests and US kidneys).pdf (pp.1–5) [22] Lecture slides: Nephrology- Acute kidney injury.pdf (Terminology, p.2) [23] Senior notes: Block A - Nephrology Interactive Tutorial.pdf (Case P2 — creatinine interpretation, p.3) [24] Senior notes: Block A - An old man with bone pain and anaemia_ multiple myeloma; monoclonal gammopathy.pdf (Myeloma workup, p.20) [25] Senior notes: MBBS Final MB (Medicine) (Felix PY Lai).pdf (Urinalysis — cast matrix, p.928) [26] Senior notes: Block A - Two cases of polyuria and polydipsia.pdf (Avoiding contrast in renal impairment, p.4)
Management of Acute Tubular Necrosis
Here is the most important thing to understand about managing ATN — and it's deceptively simple:
Management relies on aggressive treatment of the factors that precipitated ATN (e.g. hydration and cessation of offending drug) [2].
There is no specific drug that reverses ATN. No magic pill regenerates dead tubular cells faster. The tubules regenerate on their own — your job as the doctor is to:
- Remove the insult (stop the nephrotoxin, treat the sepsis, restore perfusion)
- Keep the patient alive while the tubules regenerate (manage life-threatening complications)
- Provide renal replacement therapy if the kidneys cannot sustain life during the recovery period
This is fundamentally a supportive care condition. Let's build the management algorithm from first principles.
2. Step-by-Step Management
STEP 1: Immediate Priorities — The ABC Approach
"Ensure and manage ABC: 'A dead person has no renal function.'" [5]
This is the critical care mantra. Before you worry about creatinine, worry about whether the patient is alive and stable.
- Treat hypoxaemia with supplemental O₂. Why? Patients with pulmonary oedema from fluid overload may be severely hypoxic. Oxygen delivery to the already-ischaemic kidneys is also impaired if the patient is hypoxic.
- If severe pulmonary oedema → consider non-invasive ventilation (CPAP/BiPAP) or intubation if respiratory failure.
Treat hypotension by aggressive fluid resuscitation [5].
- If hypovolaemic: Crystalloid (0.9% NaCl or balanced crystalloid like Hartmann's) — bolus 250–500 mL then reassess.
- If septic shock: Fluids + vasopressors (noradrenaline first-line) per Surviving Sepsis Campaign guidelines.
- If cardiogenic shock: Avoid excessive fluids (will worsen pulmonary oedema); inotropes (dobutamine) ± mechanical circulatory support.
Common Exam Pitfall
"It takes time for urine output to respond → do NOT give diuretics" in the initial resuscitation phase of AKI [5]. Diuretics do not reverse ATN and can worsen hypovolaemia if the underlying problem is prerenal. Diuretics are only used once the patient is fluid overloaded and you need to remove fluid.
Consider and reverse use of any nephrotoxic drugs: NSAIDs, aminoglycosides, ACEI/ARB [5].
This is one of the most impactful interventions. Review the drug chart meticulously:
| Drug to Stop | Why |
|---|---|
| NSAIDs | Inhibit prostanoid production → impaired regulation of renal blood flow; prostaglandins prevent excessive vasoconstriction of renal afferent and efferent arterioles [10] |
| Aminoglycosides | Direct tubular toxicity — concentrated within the kidney at the phospholipid brush border of the proximal tubular epithelium [6][8] |
| ACEI/ARB | Reduce GFR by vasodilating the efferent arteriole → decreased intraglomerular pressure. Never prescribe ACEI and ARB together [10] |
| Calcineurin inhibitors (ciclosporin, tacrolimus) | Afferent arteriolar vasoconstriction → ↓ renal blood flow [9] |
| Contrast agents | Avoid further contrast. Contrast nephropathy usually spontaneously resolves in 1 week [1] |
| Metformin | Does not cause ATN but accumulates in renal failure → risk of lactic acidosis [9] |
Also dose-adjust all renally cleared drugs (e.g. reduce antibiotic doses, avoid nephrotoxic antibiotics if alternatives exist).
STEP 2: Identify and Treat the Underlying Cause
The management of ATN is fundamentally about treating what caused it. The specific treatment depends on the aetiology:
- Restore renal perfusion: IV fluids, blood transfusion (if haemorrhagic shock), vasopressors (if distributive shock).
- Treat the underlying shock: e.g. antibiotics + source control for septic shock, PCI for cardiogenic shock post-MI, adrenaline for anaphylactic shock.
- Cessation of the offending drug is the single most important intervention [2].
- For aminoglycosides: Stop the drug. If aminoglycoside must continue (e.g. infective endocarditis where alternatives are limited), then: good hydration, adjust dose, serial monitoring of drug levels and renal function, biomarkers of renal damage [8].
- Why do we still use aminoglycosides if they're nephrotoxic? Because for certain infections (e.g. endocarditis with Enterococcus, serious Gram-negative infections), the bactericidal synergy with beta-lactams is irreplaceable. The key is to use extended-interval dosing (once-daily) which reduces trough levels and nephrotoxicity while maintaining peak efficacy.
- For cisplatin: Focal ATN, damage to distal tubule and collecting duct [8]. Aggressive IV hydration before and after cisplatin infusion. Monitor for electrolyte aberrations: hypomagnesaemia (70–80% of patients, may persist for months), hypocalcaemia, hypokalaemia [8].
Mx: usually spontaneously resolves in 1 week [1].
- Supportive care only. Ensure adequate hydration. Monitor creatinine.
- Prevention (for future contrast exposure): Avoid contrast CT if eGFR < 30. If absolute indication, use N-acetylcysteine + IV volume expansion before administration [1].
- Prevention protocol: IV hydration with isotonic fluids (NaCl or NaHCO₃) — standard: 0.9% NS at 1 mL/kg/h for 6–12 hours before and 6–12 hours after the procedure [27].
Contrast Nephropathy Prevention - Exam Favourite
Threshold for contrast nephropathy prevention: eGFR < 60 mL/min/1.73m². Contraindication to contrast: eGFR < 30 mL/min/1.73m² [27]. If contrast must be given to a high-risk patient:
- IV hydration with 0.9% NS at 1 mL/kg/h for 6–12h pre- and post-procedure
- N-acetylcysteine (NAC) — antioxidant that may reduce oxidative stress in the renal medulla (evidence is debated but still widely used)
- Use low-osmolar or iso-osmolar contrast agents
- Use the minimum volume of contrast necessary
Treat/prevent AKI: Aggressive hydration — IV NS ~100–200 mL/h [11].
- Why aggressive fluids? To dilute the intratubular myoglobin concentration, maintain tubular flow (preventing cast formation and obstruction), and expand intravascular volume (patients are hypovolaemic from third-spacing into injured muscles).
- Bicarbonate infusion: Alkalinisation of the urine (target urine pH > 6.5) reduces myoglobin-induced oxidative injury and prevents myoglobin cast formation (myoglobin is less toxic and more soluble in alkaline urine) [11].
- Treat electrolyte disturbances: HyperK, hyperphosphataemia, hypoCa [11].
- Dialysis if necessary [11].
- Treat the underlying cause (stop statins, treat compartment syndrome, etc.).
Myeloma kidney is an emergency, must act immediately to save the kidney → possible that with good and early treatment, kidney can be saved [24].
- Urgent chemotherapy to reduce light chain production.
- High-volume IV hydration to flush casts.
- Avoid nephrotoxins (contrast, NSAIDs, diuretics).
- Consider plasmapheresis or high cut-off dialysis to remove circulating free light chains.
- Avoid alkalinisation (unlike rhabdomyolysis) — alkaline pH promotes Tamm-Horsfall/light chain co-precipitation.
STEP 3: Manage Life-Threatening Complications
These are the complications that can kill the patient before the tubules have time to regenerate. Use the mnemonic AEIOU (which is also the mnemonic for dialysis indications):
HyperK > 6 require urgent Tx [1].
Hyperkalaemia is the most immediately dangerous complication of ATN. It can cause fatal cardiac arrhythmias (VF, asystole).
Management — Three-Step Approach:
| Step | Treatment | Mechanism | Onset | Duration |
|---|---|---|---|---|
| 1. Stabilise the myocardium | IV calcium gluconate 10% 10 mL over 10 min | Does NOT lower K⁺. Raises the threshold potential of cardiac myocytes, stabilising the membrane against arrhythmias. | 1–3 min | 30–60 min |
| 2. Shift K⁺ into cells | Insulin 10 U + 50 mL 50% dextrose IV | Insulin activates Na⁺/K⁺-ATPase → drives K⁺ into cells. Dextrose prevents hypoglycaemia. | 15–30 min | 4–6 h |
| Nebulised salbutamol 10–20 mg | β₂-agonist → activates Na⁺/K⁺-ATPase → shifts K⁺ intracellularly. | 15–30 min | 2–4 h | |
| IV NaHCO₃ (if acidotic) | Alkalosis drives K⁺ into cells via H⁺/K⁺ exchange. | 15–30 min | 2 h | |
| 3. Remove K⁺ from body | Oral potassium binders | Bind K⁺ in the gut in exchange for another cation. | Hours | Ongoing |
| Loop diuretics (if UO present) | Increase renal K⁺ excretion. | 30 min | While effective | |
| Dialysis | Definitive removal of K⁺ from the body. | Immediate once started | During session |
Oral potassium binders — important pharmacology:
| Drug | Mechanism | Onset | Notes |
|---|---|---|---|
| Calcium resonium (calcium polystyrene sulphonate) | Cation exchange resin — exchanges Ca²⁺ for K⁺ in the gut | Hours | Older agent; can cause constipation |
| Sodium polystyrene sulphonate (SPS, Kayexalate) | Exchanges Na⁺ for K⁺ in the gut | Hours | Rare but serious complication: colonic necrosis [28] |
| Patiromer | Binds K⁺ in the colon (non-absorbed polymer) | 4–7 hours [28] | Newer; fewer GI side effects |
| Sodium zirconium cyclosilicate (SZC, Lokelma) | Selective K⁺ trapping in the GI tract | 2 hours [28] | Fastest onset among oral binders |
Oral K Binders Are NOT For Acute Emergency
Oral potassium binders have onset time in the hours → for long-term control only. Acute phase of hyperkalaemia: use IV calcium to stabilise the rhythm first, then insulin-dextrose and inhaled beta-2 agonist [28].
The oliguric kidney cannot excrete sodium and water → volume overload → peripheral oedema → pulmonary oedema → respiratory failure.
| Treatment | Mechanism | Notes |
|---|---|---|
| Fluid restriction | Reduce intake | Essential — restrict to insensible losses + urine output |
| Sodium restriction | Reduce water retention | Low-salt diet |
| IV loop diuretics (furosemide) | Block NKCC2 in TAL → increase sodium and water excretion | Only works if there is still some residual tubular function [5]. High doses may be needed (up to furosemide 250 mg IV). If anuric → diuretics are futile. |
| Dialysis | Ultrafiltration removes fluid directly | If refractory to diuretics [5] |
- Why does it occur? The damaged tubules cannot excrete H⁺ or regenerate HCO₃⁻. Organic acids (sulphates, phosphates, lactate) accumulate → high anion gap metabolic acidosis.
- Treatment:
Risks of NaHCO₃ Therapy
Risks of NaHCO₃ include [29]:
- Hypernatraemia — each mmol of HCO₃⁻ carries 1 mmol of Na⁺ (200 mmol NaHCO₃ = more Na⁺ than 1 litre of normal saline)
- Induce hypokalaemia — by shifting K⁺ into cells (dangerous if K⁺ already low or normalising)
- Decrease ionic calcium — problematic in CKD patients with existing hypocalcaemia
- Volume expansion from the sodium load
- Paradoxical cerebral acidosis — HCO₃⁻ breaks down → CO₂ → crosses BBB → carbonic anhydrase converts to acid in brain
- NaHCO₃ is not treating the underlying cause — it only buys time [29]
If urea and other uraemic toxins accumulate to dangerous levels:
- Uraemic pericarditis → pericardial friction rub → risk of tamponade → urgent dialysis
- Uraemic encephalopathy → altered consciousness, asterixis → dialysis
- Uraemic bleeding → platelet dysfunction → DDAVP, cryoprecipitate, or dialysis
STEP 4: Supportive Care During Recovery
| Parameter | Frequency | Why |
|---|---|---|
| Urine output | Hourly | Track oliguric → diuretic transition; detect fluid overload |
| Daily weights | Daily | Most accurate measure of fluid balance |
| RFT + electrolytes | At least daily (more frequently if unstable) | Track creatinine trend, K⁺, Na⁺, Ca²⁺, PO₄ |
| Venous blood gas | As needed | Monitor acid-base status |
| Drug levels | If on renally cleared drugs | Prevent further toxicity |
- Adequate caloric intake (25–35 kcal/kg/day) — ATN is a catabolic state; under-nutrition impairs tubular regeneration.
- Protein: In non-dialysed patients, limit protein to 0.8–1.0 g/kg/day to reduce urea generation. In dialysed patients, increase to 1.2–1.5 g/kg/day (protein is lost during dialysis).
- Low potassium diet [28] — restrict fruits, vegetables, chocolate, nuts.
- Low phosphate diet — restrict dairy, processed foods.
- Sodium restriction — to limit fluid retention.
- Must monitor kidney function for many drugs → metformin, ACEI/ARB [9].
- Dose-adjust all renally cleared medications using the current eGFR or creatinine clearance.
- Avoid gadolinium-based MRI contrast if eGFR < 30 (risk of nephrogenic systemic fibrosis).
Diuretic phase: markedly increased urine output — up to 3 L/day [2].
This is a dangerous period that students often overlook:
- The recovering tubules cannot yet concentrate urine → massive water and electrolyte losses.
- Risk of dehydration: Replace fluids (IV or oral) matching urine output.
- Risk of hypokalaemia: K⁺ lost in the dilute polyuric urine → monitor K⁺ closely → supplement if needed.
- Risk of hyponatraemia: Dilute urine may carry excessive sodium losses.
- Monitor electrolytes at least twice daily during the polyuric phase.
STEP 5: Renal Replacement Therapy (Dialysis)
Dialysis is the last resort — it does not fix the underlying problem but buys time for tubular regeneration while keeping the patient alive.
Indications [5]:
| Letter | Indication | Detail |
|---|---|---|
| A | Acidosis | Metabolic acidosis with pH < 7.1 that is refractory to bicarbonate infusion [5] |
| E | Electrolyte imbalance | HyperK > 6.5 or rapidly rising K⁺ that is refractory to medical treatment [5] |
| I | Intoxication | Drug removal in overdose (e.g. methanol, ethylene glycol, lithium, salicylates) [5] |
| O | Overload | Fluid overload refractory to diuretics [5] |
| U | Uraemia | Features of uraemia: pericarditis, neuropathy, decreased mental status [5] |
AEIOU — Dialysis Indications
A = Acidosis (pH < 7.1, refractory), E = Electrolytes (hyperK > 6.5, refractory), I = Intoxication (drug overdose), O = Overload (fluid, refractory to diuretics), U = Uraemia (pericarditis, encephalopathy, neuropathy) [5]. This is one of the most commonly tested mnemonics in nephrology and critical care exams.
| Modality | Description | When to Use |
|---|---|---|
| Intermittent haemodialysis (IHD) | Blood pumped through an extracorporeal circuit with a semipermeable membrane dialyser; solutes removed by diffusion against dialysate; fluid removed by ultrafiltration. Sessions typically 3–4 hours. | Haemodynamically stable patients; most commonly used in non-ICU settings |
| Continuous renal replacement therapy (CRRT) | Continuous venovenous haemofiltration/haemodialysis via a central venous catheter; runs 24h/day at lower flow rates. | Haemodynamically unstable patients (ICU) — slower fluid removal causes less hypotension [5] |
| Peritoneal dialysis (PD) | Uses the peritoneum as a dialysis membrane; dialysate instilled into peritoneal cavity. | Rarely used for ATN in adults (more common for CKD or in paediatrics). Contraindicated if recent abdominal surgery. |
"Usually pumped venovenous haemofiltration via central venous catheter → consider admission to ICU" [5].
- No absolute contraindications in a life-threatening situation.
- Relative contraindications: severe coagulopathy (↑ bleeding risk from anticoagulation during dialysis), haemodynamic instability (use CRRT instead of IHD), inability to obtain vascular access.
Prevention is always better than cure, and many cases of ATN are iatrogenic (drug-induced or procedure-related):
| Strategy | Detail |
|---|---|
| Maintain euvolaemia in at-risk patients | Pre-hydrate before surgery, ensure adequate intake in elderly/frail patients |
| Avoid nephrotoxic drug combinations | E.g. NSAID + ACEI + diuretic ("triple whammy" → renal catastrophe) |
| Aminoglycoside stewardship | Extended-interval dosing, therapeutic drug monitoring (trough levels), shortest possible course. Protect patients via good hydration, dose adjustment, serial monitoring, biomarkers of renal damage [8] |
| Contrast nephropathy prevention | Avoid contrast if eGFR < 30. If unavoidable: IV NS 1 mL/kg/h pre- and post-procedure + NAC. Use low-osmolar agents and minimum volume [1][27] |
| Cisplatin protocol | Aggressive pre- and post-hydration, monitor Mg²⁺ closely |
| Rhabdomyolysis prevention | Early aggressive IV fluids in crush injuries, immobilised patients, status epilepticus |
| Nephrology referral | Early referral improves outcomes in complex AKI |
| Cause | Specific Treatment | Prevention |
|---|---|---|
| Ischaemic (shock) | Fluid resuscitation, vasopressors, treat underlying shock | Maintain euvolaemia, monitor high-risk surgical patients |
| Aminoglycosides | Stop drug. Hydration. Dose adjustment. Serial monitoring [8] | Extended-interval dosing, TDM, shortest course |
| Cisplatin | Stop drug. Aggressive hydration. Monitor Mg/Ca/K | Pre-/post-hydration protocol |
| Contrast | Supportive — spontaneously resolves in 1 week [1] | Avoid if eGFR < 30; IV NS + NAC pre-procedure [1][27] |
| Rhabdomyolysis | Aggressive IV NS 100–200 mL/h. Alkaline diuresis. Treat electrolytes. Dialysis if needed [11] | Early fluids in trauma/immobilisation |
| Myeloma | Urgent chemotherapy. High-volume hydration. Avoid nephrotoxins [24] | Avoid dehydration and nephrotoxins in myeloma patients |
| Sepsis | Antibiotics + source control + haemodynamic support | Early recognition and treatment of sepsis |
High Yield Summary
- ATN management = treat the precipitating cause + supportive care + manage life-threatening complications. There is no drug that directly reverses ATN.
- Immediate priorities: ABC → treat hypoxia → restore perfusion → STOP ALL NEPHROTOXIC DRUGS (NSAIDs, aminoglycosides, ACEI/ARB) [5].
- Do NOT give diuretics during initial resuscitation — they do not reverse ATN and can worsen hypovolaemia [5]. Only use diuretics for established fluid overload.
- Hyperkalaemia management (3 steps): (1) IV calcium gluconate (stabilise myocardium), (2) insulin-dextrose + salbutamol (shift K into cells), (3) K-binders or dialysis (remove K from body).
- Oral K-binders (patiromer onset 4–7h, SZC onset 2h, SPS onset hours) are for long-term control, NOT acute emergencies [28]. SPS can cause colonic necrosis [28].
- NaHCO₃ risks: hypernatraemia, hypokalaemia, ↓ ionic calcium, volume overload, paradoxical cerebral acidosis [29].
- Dialysis indications: AEIOU — Acidosis (pH < 7.1 refractory), Electrolytes (hyperK > 6.5 refractory), Intoxication, Overload (refractory), Uraemia (pericarditis/encephalopathy) [5].
- Contrast nephropathy prevention: avoid contrast if eGFR < 30; if unavoidable: IV NS 1 mL/kg/h pre- and post-procedure + NAC [1][27].
- Rhabdomyolysis ATN: aggressive IV NS 100–200 mL/h + bicarbonate to alkalinise urine [11].
- Diuretic recovery phase is dangerous: risk of dehydration and hypokalaemia from polyuria up to 3 L/day [2]. Monitor closely and replace losses.
Active Recall - Management of ATN
References
[1] Senior notes: Adrian Lui Pediatrics Notes.pdf (Acute tubular necrosis section, p.331) [2] Senior notes: Block A - Nephrotology Teaching Clinic RTD.pdf (Acute Tubular Injury section, pp.1–8) [5] Senior notes: Ryan Ho Critical Care.pdf (AKI and Renal Support — immediate approach + dialysis indications, p.26) [6] Lecture slides: GC 043. Drugs and the Kidney.pdf (Aminoglycosides slide, p.20) [8] Senior notes: Block A - Drugs and the Kidney.pdf (Aminoglycosides section, p.10; Cisplatin section, p.12; Direct toxicity drugs, p.9) [9] Senior notes: Block A - Chronic Kidney Disease and its Complications.pdf (Drug-induced kidney disease, pp.11–12) [10] Senior notes: Block A – Nephrology Data Interpretation.pdf (NSAIDs and renal impairment — Case 3, p.11) [11] Senior notes: Ryan Ho Neurology.pdf (Rhabdomyolysis management, p.196) [24] Senior notes: Block A - An old man with bone pain and anaemia_ multiple myeloma; monoclonal gammopathy.pdf (Myeloma kidney management, p.20) [27] Senior notes: MBBS Final MB (Medicine) (Felix PY Lai).pdf (Contrast nephropathy prevention, p.1032) [28] Senior notes: Block A - Chronic Kidney Disease and its Complications.pdf (Hyperkalaemia management and oral K-binders, p.28) [29] Senior notes: Block A - Electrolyte and Acid-Base Disorders.pdf (NaHCO₃ therapy risks, p.8)
Complications of Acute Tubular Necrosis
ATN is not just "elevated creatinine" — it is a multisystem emergency that can kill through its complications long before the tubules have time to regenerate. Understanding the complications of ATN requires understanding what the kidney actually does in health, and then logically deducing what goes wrong when it stops doing it.
Think of the kidney as performing five critical homeostatic functions:
- Excreting waste products (urea, creatinine, uraemic toxins)
- Regulating fluid volume (sodium and water excretion)
- Maintaining electrolyte balance (K⁺, Ca²⁺, PO₄³⁻, Mg²⁺, Na⁺)
- Maintaining acid-base balance (H⁺ excretion, HCO₃⁻ regeneration)
- Endocrine function (erythropoietin, 1,25-dihydroxyvitamin D, renin)
When ATN knocks out these functions, complications arise from each domain. We can organise them into acute (immediately life-threatening) and subacute/long-term complications.
1. Acute Life-Threatening Complications
These are the complications that dominate the oliguric phase and can kill within hours to days if not managed urgently.
HyperK ( > 6) require urgent Tx [1].
Why does it happen?
- The distal tubule and collecting duct are responsible for excreting ~90% of the body's daily K⁺ load (about 40–100 mmol/day). When these segments are damaged or GFR is drastically reduced, K⁺ cannot be excreted.
- Additional K⁺ sources in ATN: tissue breakdown (especially in rhabdomyolysis, haemolysis, tumour lysis), metabolic acidosis (drives K⁺ out of cells via H⁺/K⁺ exchange), blood transfusions (stored blood has elevated K⁺).
Clinical consequences:
- Cardiac toxicity — this is the killing mechanism. The ECG progresses through a predictable sequence as K⁺ rises:
- 5.5–6.5 mmol/L: Peaked T waves (↑ K⁺ accelerates phase 3 repolarisation)
- 6.5–7.5 mmol/L: Flattened P waves, prolonged PR interval (atrial conduction slows)
- 7.0–8.0 mmol/L: Widened QRS (ventricular conduction slows)
-
8.0 mmol/L: Sine wave pattern → VF → asystole
- Neuromuscular: Weakness, paraesthesiae, areflexia (depolarisation block of skeletal muscle).
Hyperkalaemia: symptoms (arrhythmia, weakness) usually only when K > 6 [5].
Management — as covered in the prior section: IV calcium gluconate → insulin-dextrose + nebulised salbutamol → K⁺ binders / dialysis [5].
High Yield - Hyperkalaemia Is the #1 Killer in ATN
Hyperkalaemia is the most immediately dangerous complication of ATN. Always check K⁺ and ECG urgently in any patient with AKI. Treatment must be initiated even before the exact K⁺ level returns if ECG changes are present.
Fluid overload: peripheral oedema, hypertension, pulmonary oedema [5].
Why does it happen?
- The oliguric kidney cannot excrete sodium and water → positive fluid balance → expansion of the extracellular fluid volume.
- Every litre of IV fluid given (for resuscitation, drug dilution, or nutrition) that the kidney cannot excrete accumulates in the body.
- Na⁺ retention → water retention (water follows sodium osmotically) → expanded intravascular volume → ↑ preload → ↑ hydrostatic pressure in pulmonary capillaries → transudation of fluid into alveoli → pulmonary oedema.
Clinical consequences:
- Peripheral oedema — bilateral, pitting, dependent.
- Hypertension — from volume expansion (the RAAS is also activated, compounding this).
- Pulmonary oedema — dyspnoea, orthopnoea, pink frothy sputum, bilateral crepitations.
- CXR: pulmonary oedema (fluid overload), bat-wing appearance [1]. Bat-wing appearance without cardiomegaly may suggest pulmonary haemorrhage rather than cardiac pulmonary oedema [1].
- Pleural effusions — transudative, from volume overload.
- Severe cases → respiratory failure requiring non-invasive ventilation or intubation.
Management: Fluid restriction, sodium restriction, IV loop diuretics (furosemide), and if refractory → dialysis (ultrafiltration) [5].
Metabolic acidosis and hyperkalaemia during the oliguric phase [2].
Why does it happen?
- The kidney normally excretes ~70 mmol of H⁺ per day (produced from protein metabolism). In ATN, the damaged tubules cannot:
- Secrete H⁺ into the urine (via H⁺-ATPase and H⁺/K⁺-ATPase in the collecting duct)
- Regenerate HCO₃⁻ (the proximal tubule reclaims filtered HCO₃⁻, but this is impaired)
- Generate new HCO₃⁻ via ammoniagenesis (the proximal tubule generates NH₃ from glutamine, which buffers H⁺ in the urine — this process is impaired in ATN)
- Simultaneously, organic acids accumulate: sulphates (from protein metabolism), phosphates, and lactate (especially in sepsis-associated ATN).
- The result: high anion gap metabolic acidosis (HAGMA).
Clinical consequences:
- Kussmaul breathing — deep, laboured breathing as the respiratory system attempts to compensate by blowing off CO₂ (respiratory alkalosis to offset metabolic acidosis).
- Worsens hyperkalaemia — acidosis drives K⁺ out of cells via H⁺/K⁺ exchange (for every 0.1 drop in pH, K⁺ rises ~0.3–0.6 mmol/L).
- Decreased cardiac contractility — severe acidosis (pH < 7.1) depresses myocardial function.
- Vasodilation — acidosis causes peripheral vasodilation → worsens hypotension → worsens renal perfusion → vicious cycle.
Management: Treat underlying cause, IV NaHCO₃ (temporising), dialysis if pH < 7.1 and refractory to bicarbonate [5].
Why does it happen?
- Urea and other nitrogenous waste products (indoles, guanidino compounds, β₂-microglobulin, advanced glycation end-products) accumulate when the kidney cannot excrete them.
- High plasma urea level during the oliguric phase [2].
- Uraemic toxins are directly toxic to multiple organ systems.
Clinical consequences of uraemia:
| System | Complication | Mechanism |
|---|---|---|
| Cardiovascular | Uraemic pericarditis | Uraemic toxins directly irritate the pericardium → fibrinous pericarditis → pericardial friction rub → risk of haemorrhagic pericardial effusion → cardiac tamponade |
| Neurological | Uraemic encephalopathy | Uraemic toxins cross the BBB → disrupt neurotransmitter function → altered mental status, asterixis (flapping tremor), myoclonus, seizures, coma |
| Peripheral neuropathy | Uraemic toxins damage peripheral nerves → distal symmetric sensorimotor neuropathy (burning feet, paraesthesiae, weakness) | |
| Haematological | Uraemic bleeding | Uraemic toxins impair platelet function (↓ platelet adhesion and aggregation, ↓ von Willebrand factor multimer activity) → prolonged bleeding time despite normal platelet count and normal PT/APTT. Clinically: GI bleeding, epistaxis, bruising. |
| Gastrointestinal | Nausea, vomiting, anorexia | Uraemic toxins irritate gastric mucosa and stimulate the chemoreceptor trigger zone. Urea is broken down to ammonia by gut urease-producing bacteria → gastric irritation. |
| Uraemic fetor | Ammonia smell on breath (breakdown of urea in saliva) | |
| Dermatological | Uraemic frost | Deposition of urea crystals on skin (very rare, only in severe untreated uraemia). Pruritus (uraemic itch) from accumulation of middle molecules. |
| Immunological | Impaired immune function | Uraemic toxins suppress lymphocyte and neutrophil function → ↑ susceptibility to infection |
Indications for dialysis include features of uraemia: pericarditis, neuropathy, decreased mental status [5]. The presence of uraemic pericarditis is an absolute indication for urgent dialysis — the risk of tamponade is immediately life-threatening.
| Complication | Mechanism | Clinical Effects |
|---|---|---|
| Hyponatraemia | Dilutional — water retention exceeds sodium retention; also, inappropriate ADH release can occur in severely ill patients | Confusion, seizures (if acute and severe, Na⁺ < 120), nausea |
| Hypocalcaemia | (1) ↓ 1,25-dihydroxyvitamin D synthesis (1-alpha hydroxylase in the damaged PCT is impaired), (2) hyperphosphataemia (PO₄ binds Ca²⁺ → CaPO₄ complexes precipitate), (3) skeletal resistance to PTH. Especially prominent in rhabdomyolysis [1] | Tetany, Trousseau's sign, Chvostek's sign, perioral paraesthesiae, prolonged QT → arrhythmias |
| Hyperphosphataemia | ↓ renal PO₄ excretion + release from damaged cells (rhabdomyolysis, tumour lysis) | Worsens hypocalcaemia via CaPO₄ precipitation; metastatic calcification if Ca × PO₄ product > 4.4 mmol²/L² |
| Hypomagnesaemia | Particularly in cisplatin-induced ATN — 70–80% of patients, may persist for months [8] | Refractory hypokalaemia (Mg²⁺ is required for the Na⁺/K⁺-ATPase and ROMK channel), refractory hypocalcaemia, arrhythmias, tremor |
| Hyperuricaemia | ↓ renal uric acid excretion + release from damaged cells (tumour lysis syndrome) | Gout flares; further tubular crystal deposition |
Cisplatin Electrolyte Complications - Exam Point
Cisplatin causes tubular diseases resulting in hypokalaemia and hypomagnesaemia [9][30]. The hypomagnesaemia may persist for months [8] because cisplatin damages the distal tubule where the majority of Mg²⁺ reabsorption occurs (via the TRPM6 channel). Low Mg²⁺ then causes refractory hypokalaemia because Mg²⁺ is needed for the ROMK K⁺ channel to function properly in the collecting duct — you cannot correct the hypokalaemia until you correct the hypomagnesaemia first.
Students often forget that the recovery phase has its own set of dangerous complications — in some ways, the diuretic phase can be more treacherous than the oliguric phase if the clinician is not vigilant.
Diuretic phase: markedly increased urine output — up to 3 L/day [2].
| Complication | Mechanism | Management |
|---|---|---|
| Dehydration / hypovolaemia | Regenerating tubules cannot yet concentrate urine → massive water loss. Accumulated solutes (urea, Na⁺) act as osmotic diuretics dragging water out. | Replace fluids (IV or oral) matching urine output. Daily weights. |
| Hypokalaemia | K⁺ lost in the dilute polyuric urine; also, the recovering tubules initially over-excrete K⁺ | Monitor K⁺ at least twice daily. IV/oral K⁺ supplementation as needed. |
| Hyponatraemia | Excessive Na⁺ loss in the dilute urine | Monitor Na⁺ closely. May need isotonic fluid replacement. |
| Hypophosphataemia | Phosphate excretion in recovering tubules | Monitor and supplement if symptomatic. |
The Polyuric Phase Trap
A common exam scenario: a patient recovering from ATN suddenly becomes hypotensive and tachycardic with rising creatinine — the temptation is to think ATN has worsened. In reality, the patient has become volume-depleted during the diuretic phase because nobody replaced the 3 L/day of urine being produced. This is a prerenal AKI on top of recovering ATN — and is entirely preventable with careful fluid management.
Why are ATN patients at increased risk of infection?
- Uraemia impairs immune function (as above) — suppressed lymphocyte and neutrophil function.
- Invasive lines: Central venous catheters (for dialysis), urinary catheters, arterial lines → portals of entry for nosocomial infection.
- Underlying critical illness: Many ATN patients are in the ICU with sepsis, surgical wounds, or ventilator-associated pneumonia.
- Malnutrition: The catabolic state of AKI depletes protein reserves → impaired immune response.
Consequences:
- Nosocomial infections (UTI, line sepsis, pneumonia) are a leading cause of mortality in hospitalised ATN patients.
- Infection can also prolong or worsen ATN by causing further haemodynamic instability and tubular injury.
| Complication | Mechanism |
|---|---|
| Arrhythmias | Hyperkalaemia (most dangerous), hypocalcaemia (prolonged QT), hypomagnesaemia, metabolic acidosis — all arrhythmogenic |
| Heart failure / pulmonary oedema | Fluid overload → volume-dependent hypertension → ↑ afterload and preload → decompensated heart failure |
| Uraemic pericarditis | Uraemic toxins → fibrinous pericarditis → pericardial effusion → risk of tamponade |
| Accelerated atherosclerosis | AKI triggers endothelial dysfunction, inflammation, and oxidative stress → increased cardiovascular risk even after renal recovery |
| Complication | Mechanism |
|---|---|
| Anaemia | Multifactorial: (1) ↓ erythropoietin production by damaged peritubular interstitial cells, (2) shortened RBC survival in uraemic milieu, (3) haemodilution from fluid overload, (4) blood loss (GI bleeding from uraemic gastritis, frequent blood sampling, blood retained in dialysis circuit) |
| Coagulopathy / bleeding tendency | Uraemic platelet dysfunction — impaired adhesion and aggregation despite normal platelet count. Also: DIC may occur if ATN is caused by sepsis or obstetric complications [1] |
CBC, clotting: anaemia (CKD, MAHA), coagulopathy (DIC) [1] — these must be checked in the initial evaluation of any AKI.
This is the most important long-term complication and is often under-appreciated.
Why does ATN lead to CKD?
- If the insult is severe enough to cause basement membrane disruption (tubulorrhexis with loss of the scaffold for regeneration), the tubules cannot regenerate properly.
- Chronic tubulointerstitial nephritis → interstitial fibrosis → tubular atrophy [2] — this is the final common pathway to CKD regardless of the initial insult.
- Repeated episodes of AKI have a cumulative damaging effect — each episode increases the risk of subsequent CKD.
- Prolonged pre-renal and post-renal disease will progress to become ATN and tubulointerstitial fibrosis respectively [5].
Evidence:
- Studies show that ~20–50% of patients who survive severe ATN requiring dialysis have incomplete renal recovery and are left with some degree of CKD.
- ~5–10% of severe ATN patients never recover renal function and require permanent renal replacement therapy.
Systemic manifestations of CKD that may develop if ATN progresses [9]:
- Metabolic acidosis
- Hypertension, LVH
- Congestive cardiac failure → systolic HF, HFrEF
- Anaemia — normochromic normocytic anaemia → lack of erythropoietin
- CKD-MBD (mineral and bone disorder) — high or low PTH, bone biochemistry abnormality, vascular calcification
Late chronic allograft dysfunction in the transplant setting is characterised by slow progressive decrease in renal graft function, proteinuria, hypertension and histological features of interstitial fibrosis and tubular atrophy [20] — the same fibrotic pathway seen after severe ATN.
AKI-to-CKD Transition
Every episode of AKI leaves a "scar" on the kidney. Even if creatinine returns to baseline, there may be subclinical nephron loss. This is why patients who recover from ATN need long-term follow-up with serial RFT, urinalysis, and blood pressure monitoring. The AKI-to-CKD transition is now recognised as a major public health issue.
In severe cases — particularly sepsis-associated ATN in the ICU — the kidney failure occurs as part of a broader multi-organ dysfunction syndrome:
| System | Complication |
|---|---|
| Respiratory | ARDS (acute respiratory distress syndrome) |
| Cardiovascular | Septic shock |
| Hepatic | Jaundice, GI bleeding, paralytic ileus |
| Renal | ATN / AKI |
| Neurological | Septic encephalopathy, critical illness polyneuropathy |
| Haematological | DIC |
ATN in the context of MODS carries a much higher mortality (~50–70%) than isolated ATN, because the patient is failing on multiple fronts simultaneously.
| Cause of ATN | Specific Complications |
|---|---|
| Rhabdomyolysis | Compartment syndrome, DIC, hyperK-induced cardiac arrest, hypoCa [11][31] |
| Haemolysis | Jaundice, haemoglobinuria, DIC (if intravascular haemolysis is severe, e.g. ABO-incompatible transfusion) |
| Contrast nephropathy | Usually mild and self-limiting; rarely progresses to requiring dialysis [1] |
| Aminoglycoside ATN | Ototoxicity / vestibular toxicity — these are independent organ toxicities, not renal complications per se, but frequently co-exist [6][8] |
| Cisplatin ATN | Ototoxicity, GI side effects, myelosuppression, electrolyte aberrations (hypoMg persisting months, hypoCa, hypoK) [8]. Can be irreversible [8]. |
| System | Complications | Mechanism |
|---|---|---|
| Electrolyte | Hyperkalaemia, hyponatraemia, hypocalcaemia, hyperphosphataemia, hypomagnesaemia | ↓ renal excretion/regulation |
| Acid-base | High anion gap metabolic acidosis | ↓ H⁺ excretion, ↓ HCO₃⁻ regeneration, organic acid accumulation |
| Fluid | Fluid overload, pulmonary oedema, hypertension (oliguric phase); dehydration, hypovolaemia (diuretic phase) | ↓ Na⁺/water excretion; then loss of concentrating ability |
| Cardiovascular | Arrhythmias, heart failure, uraemic pericarditis | Electrolyte disturbance, volume overload, uraemic toxins |
| Neurological | Uraemic encephalopathy, peripheral neuropathy, seizures | Uraemic toxin accumulation |
| Haematological | Anaemia, uraemic bleeding, DIC | ↓ EPO, platelet dysfunction, consumptive coagulopathy |
| GI | Nausea, vomiting, anorexia, GI bleeding, uraemic fetor | Uraemic toxins, gastric irritation |
| Immune | ↑ infection susceptibility | Uraemia-induced immunosuppression, invasive lines |
| Long-term | Progression to CKD, need for permanent dialysis | Tubulointerstitial fibrosis, incomplete tubular regeneration |
| Multisystem | MODS (ARDS, septic shock, DIC, hepatic failure) | Part of systemic critical illness |
High Yield Summary
- Hyperkalaemia (K⁺ > 6 mmol/L) is the most immediately life-threatening complication of ATN — can cause VF and cardiac arrest. Peaked T waves → widened QRS → sine wave → death [1][5].
- Fluid overload → pulmonary oedema is the second major acute killer — treat with diuretics/dialysis, not more fluids [5].
- Metabolic acidosis (HAGMA) — accumulation of H⁺, sulphates, phosphates, lactate. Worsens hyperkalaemia. Dialyse if pH < 7.1 [5].
- Uraemic complications — pericarditis (→ tamponade, absolute dialysis indication), encephalopathy (asterixis, seizures), bleeding (platelet dysfunction), infection susceptibility [5].
- Diuretic phase complications are often forgotten: dehydration and hypokalaemia from polyuria up to 3 L/day [2]. Monitor closely and replace losses.
- Cisplatin: hypomagnesaemia in 70–80%, may persist for months; can cause refractory hypokalaemia [8][9].
- ATN → CKD transition: 20–50% of severe ATN patients have incomplete recovery. Every AKI episode leaves a "scar" → long-term follow-up with RFT is essential.
- In ICU/sepsis context, ATN is often part of MODS — mortality ~50–70% [12].
- Rhabdomyolysis ATN complications: compartment syndrome, DIC, severe hyperK, hypoCa [11].
- Aminoglycoside ATN coexists with ototoxicity/vestibular toxicity — two independent organ toxicities from the same drug [6][8].
Active Recall - Complications of ATN
References
[1] Senior notes: Adrian Lui Pediatrics Notes.pdf (Acute tubular necrosis section, p.331) [2] Senior notes: Block A - Nephrotology Teaching Clinic RTD.pdf (Clinical course of ATN — oliguric and diuretic phases, pp.1–7) [5] Senior notes: Ryan Ho Critical Care.pdf (AKI management — complications and dialysis indications, p.26) [6] Lecture slides: GC 043. Drugs and the Kidney.pdf (Aminoglycosides — nephrotoxicity, ototoxicity, p.20) [8] Senior notes: Block A - Drugs and the Kidney.pdf (Aminoglycosides section p.10; Cisplatin section pp.12–13) [9] Senior notes: Block A - Chronic Kidney Disease and its Complications.pdf (Drug-induced kidney disease pp.11–12; CKD manifestations p.12) [11] Senior notes: Ryan Ho Neurology.pdf (Rhabdomyolysis — complications, p.196) [12] Senior notes: MBBS Final MB (Surgery) (Felix PY Lai).pdf (MODS in sepsis, p.36) [20] Senior notes: MBBS Final MB (Surgery) (Felix PY Lai).pdf (Chronic allograft dysfunction, p.886) [30] Lecture slides: GC 034. Chronic Kidney Disease and its Complications [update 2025].pdf (Cisplatin — tubular diseases, p.30) [31] Senior notes: MBBS Final MB (Surgery) (Felix PY Lai).pdf (Rhabdomyolysis complications — compartment syndrome, cardiac arrhythmia, AKI, p.929)
High Yield Summary
- ATN = most common cause of intrinsic AKI in hospitalised patients.
- Two major causes: Ischaemic (progression of prerenal failure) and Nephrotoxic (aminoglycosides, cisplatin, contrast, myoglobin, etc.).
- Most vulnerable segments: S3 segment of PCT and thick ascending limb of Loop of Henle in the outer medulla — high metabolic demand, borderline O₂ supply.
- Pathophysiology chain: ATP depletion → loss of cell polarity → brush border loss → cell necrosis/apoptosis → sloughing → cast formation → tubular obstruction + backleak + TGF activation → ↓ GFR.
- Clinical phases: Oliguric phase (↓ urine, ↑ urea, metabolic acidosis, hyperkalaemia) → Diuretic phase (up to 3 L/day, risk of dehydration/hypokalaemia) → Recovery.
- Pathognomonic finding: "Muddy brown granular casts" on urinalysis.
- FENa > 2% in ATN vs < 1% in prerenal (exception: contrast nephropathy FENa < 1%).
- Non-oliguric ATN: aminoglycosides and cisplatin — creatinine rises but urine output normal/increased due to impaired tubular concentrating ability.
- Aminoglycoside histopathology: rarification then disappearance of brush border; enlarged lysosomes with myeloid bodies; mitochondrial swelling; tubular necrosis; regeneration.
- Contrast nephropathy: Cr rises 24–48h post-contrast, peaks 3–5 days, resolves 7–14 days. Prevention: avoid if eGFR < 30, use NAC + IV hydration.
High Yield Summary
- The first step in any AKI is to classify into prerenal ( > 50%), intrinsic renal ( < 50%), post-renal ( < 10%) [4][5].
- Prerenal vs ATN is the most important differential: FENa < 1% = prerenal; FENa > 2% = ATN (exception: contrast nephropathy FENa < 1%) [1][13].
- Muddy brown granular casts = ATN; WBC casts + sterile pyuria = AIN; RBC casts = GN; bland sediment = prerenal or HRS [1][2].
- AIN classic triad: fever + eosinophilia + rash (only ~10%). Key drugs: penicillins, allopurinol, rifampicin, PPIs, NSAIDs [2][9][17].
- NSAIDs can cause ATN (via ↓ prostaglandins → ↓ renal perfusion), AIN, and nephrotic syndrome (MCD + AIN) — a single drug, three mechanisms [9][17].
- Always exclude post-renal obstruction with renal USS — it is rapidly reversible [5].
- Prolonged prerenal AKI → ischaemic ATN; prolonged post-renal obstruction → tubulointerstitial fibrosis — both become intrinsic disease if not corrected [5].
- In post-transplant setting, ATN differential includes acute rejection, vascular thrombosis, CsA/tacrolimus toxicity, ureteric obstruction, urinary leak [20].
High Yield Summary
- ATN diagnosis = KDIGO AKI criteria PLUS clinical context PLUS characteristic urinalysis PLUS biochemical indices.
- KDIGO AKI: ↑ Cr ≥ 26.5 µmol/L in 48h, OR ≥ 1.5× baseline in 7 days, OR UO < 0.5 mL/kg/h for ≥ 6h.
- Pathognomonic urine finding: muddy brown granular casts + free renal tubular epithelial cells.
- FENa > 2% = ATN; < 1% = prerenal. Exception: contrast nephropathy FENa < 1%.
- FENa formula: (U_Na × P_Cr) / (P_Na × U_Cr) × 100%. If on diuretics, use FEUrea instead.
- Renal USS: essential to exclude post-renal obstruction. Normal-sized kidneys in ATN; small kidneys suggest CKD.
- Renal biopsy: not routine — indicated if cause unclear, persistent oliguria > 6 weeks, features of GN/vasculitis, or post-transplant setting.
- ATN histopathology: tubulorrhexis, loss of brush border, enlarged lysosomes with myeloid bodies, mitochondrial swelling, necrosis, regeneration.
- Serum Cr is insensitive: GFR already ↓ 50% when Cr first rises. Newer biomarkers (NGAL, KIM-1) detect injury earlier but are not routine.
- Always send serology (ASLO, ANA, ANCA, anti-GBM, C3/4) to exclude GN/vasculitis — not to diagnose ATN, but to exclude its mimics.
High Yield Summary
- ATN management = treat the precipitating cause + supportive care + manage life-threatening complications. There is no drug that directly reverses ATN.
- Immediate priorities: ABC → treat hypoxia → restore perfusion → STOP ALL NEPHROTOXIC DRUGS (NSAIDs, aminoglycosides, ACEI/ARB) [5].
- Do NOT give diuretics during initial resuscitation — they do not reverse ATN and can worsen hypovolaemia [5]. Only use diuretics for established fluid overload.
- Hyperkalaemia management (3 steps): (1) IV calcium gluconate (stabilise myocardium), (2) insulin-dextrose + salbutamol (shift K into cells), (3) K-binders or dialysis (remove K from body).
- Oral K-binders (patiromer onset 4–7h, SZC onset 2h, SPS onset hours) are for long-term control, NOT acute emergencies [28]. SPS can cause colonic necrosis [28].
- NaHCO₃ risks: hypernatraemia, hypokalaemia, ↓ ionic calcium, volume overload, paradoxical cerebral acidosis [29].
- Dialysis indications: AEIOU — Acidosis (pH < 7.1 refractory), Electrolytes (hyperK > 6.5 refractory), Intoxication, Overload (refractory), Uraemia (pericarditis/encephalopathy) [5].
- Contrast nephropathy prevention: avoid contrast if eGFR < 30; if unavoidable: IV NS 1 mL/kg/h pre- and post-procedure + NAC [1][27].
- Rhabdomyolysis ATN: aggressive IV NS 100–200 mL/h + bicarbonate to alkalinise urine [11].
- Diuretic recovery phase is dangerous: risk of dehydration and hypokalaemia from polyuria up to 3 L/day [2]. Monitor closely and replace losses.
High Yield Summary
- Hyperkalaemia (K⁺ > 6 mmol/L) is the most immediately life-threatening complication of ATN — can cause VF and cardiac arrest. Peaked T waves → widened QRS → sine wave → death [1][5].
- Fluid overload → pulmonary oedema is the second major acute killer — treat with diuretics/dialysis, not more fluids [5].
- Metabolic acidosis (HAGMA) — accumulation of H⁺, sulphates, phosphates, lactate. Worsens hyperkalaemia. Dialyse if pH < 7.1 [5].
- Uraemic complications — pericarditis (→ tamponade, absolute dialysis indication), encephalopathy (asterixis, seizures), bleeding (platelet dysfunction), infection susceptibility [5].
- Diuretic phase complications are often forgotten: dehydration and hypokalaemia from polyuria up to 3 L/day [2]. Monitor closely and replace losses.
- Cisplatin: hypomagnesaemia in 70–80%, may persist for months; can cause refractory hypokalaemia [8][9].
- ATN → CKD transition: 20–50% of severe ATN patients have incomplete recovery. Every AKI episode leaves a "scar" → long-term follow-up with RFT is essential.
- In ICU/sepsis context, ATN is often part of MODS — mortality ~50–70% [12].
- Rhabdomyolysis ATN complications: compartment syndrome, DIC, severe hyperK, hypoCa [11].
- Aminoglycoside ATN coexists with ototoxicity/vestibular toxicity — two independent organ toxicities from the same drug [6][8].
Acute Interstitial Nephritis
Acute inflammatory condition of the renal interstitium and tubules, most commonly triggered by drugs, infections, or autoimmune processes, leading to a rapid decline in kidney function.
Chronic Interstitial Nephritis
Chronic interstitial nephritis is a progressive tubulointerstitial kidney disease characterized by chronic inflammation and fibrosis of the renal interstitium, leading to tubular atrophy and gradual decline in renal function.